{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:08Z","timestamp":1792664588749,"version":"4.5.0"},"reference-count":394,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibrosis is a pathological process, that could result in permanent scarring and impairment of the physiological function of the affected organ; this condition which is categorized under the term organ failure could affect various organs in different situations. The involvement of the major organs, such as the lungs, liver, kidney, heart, and skin, is associated with a high rate of morbidity and mortality across the world. Fibrotic disorders encompass a broad range of complications and could be traced to various illnesses and impairments; these could range from simple skin scars with beauty issues to severe rheumatologic or inflammatory disorders such as systemic sclerosis as well as idiopathic pulmonary fibrosis. Besides, the overactivation of immune responses during any inflammatory condition causing tissue damage could contribute to the pathogenic fibrotic events accompanying the healing response; for instance, the inflammation resulting from tissue engraftment could cause the formation of fibrotic scars in the grafted tissue, even in cases where the immune system deals with hard to clear infections, fibrotic scars could follow and cause severe adverse effects. A good example of such a complication is post-Covid19 lung fibrosis which could impair the life of the affected individuals with extensive lung involvement. However, effective therapies that halt or slow down the progression of fibrosis are missing in the current clinical settings. Considering the immunomodulatory and regenerative potential of distinct stem cell types, their application as an anti-fibrotic agent, capable of attenuating tissue fibrosis has been investigated by many researchers. Although the majority of the studies addressing the anti-fibrotic effects of stem cells indicated their potent capabilities, the underlying mechanisms, and pathways by which these cells could impact fibrotic processes remain poorly understood. Here, we first, review the properties of various stem cell types utilized so far as anti-fibrotic treatments and discuss the challenges and limitations associated with their applications in clinical settings; then, we will summarize the general and organ-specific mechanisms and pathways contributing to tissue fibrosis; finally, we will describe the mechanisms and pathways considered to be employed by distinct stem cell types for exerting anti-fibrotic events.<\/jats:p>","DOI":"10.1186\/s13287-024-03782-5","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:02:17Z","timestamp":1718668937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Stem cell-based therapy for fibrotic diseases: mechanisms and pathways"],"prefix":"10.1186","volume":"15","author":[{"given":"Marjan","family":"Taherian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria","family":"Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-9483","authenticated-orcid":false,"given":"Nazanin","family":"Mojtabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"issue":"3","key":"3782_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","volume":"117","author":"TA Wynn","year":"2007","unstructured":"Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Investig. 2007;117(3):524\u20139.","journal-title":"J Clin Investig"},{"issue":"2","key":"3782_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"T Wynn","year":"2008","unstructured":"Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathology: J Pathological Soc Great Br Irel. 2008;214(2):199\u2013210.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"issue":"7","key":"3782_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18(7):1028\u201340.","journal-title":"Nat Med"},{"key":"3782_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2019;65:2\u201315.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"3782_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208(7):1339\u201350.","journal-title":"J Exp Med"},{"issue":"2","key":"3782_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115(2):209\u201318.","journal-title":"J Clin Investig"},{"key":"3782_CR7","doi-asserted-by":"publisher","first-page":"117727192211354","DOI":"10.1177\/11772719221135442","volume":"17","author":"P Bayati","year":"2022","unstructured":"Bayati P, Poormoghim H, Mojtabavi N. Aberrant expression of miR-138 as a novel diagnostic biomarker in systemic sclerosis. Biomark Insights. 2022;17:11772719221135442.","journal-title":"Biomark Insights"},{"issue":"1","key":"3782_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13223-022-00734-7","volume":"18","author":"S Mehdizadeh","year":"2022","unstructured":"Mehdizadeh S, Taherian M, Bayati P, Mousavizadeh K, Pashangzadeh S, Anisian A, et al. Plumbagin attenuates bleomycin-induced lung fibrosis in mice. Allergy Asthma Clin Immunol. 2022;18(1):93.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"3782_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcb.21186","volume":"101","author":"DC Radisky","year":"2007","unstructured":"Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem. 2007;101(4):830\u20139.","journal-title":"J Cell Biochem"},{"issue":"2","key":"3782_CR10","first-page":"190","volume":"22","author":"M Taherian","year":"2023","unstructured":"Taherian M, Bayati P, Assarehzadegan MA, Soleimani M, Poormoghim H, Mojtabavi N. Insights into overlappings of fibrosis and Cancer: exploring the Tumor-related Cardinal genes in idiopathic pulmonary fibrosis. Iran J Allergy Asthma Immunol. 2023;22(2):190\u20139.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"3782_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","volume":"21","author":"E El Agha","year":"2017","unstructured":"El Agha E, Kramann R, Schneider RK, Li X, Seeger W, Humphreys BD, et al. Mesenchymal stem cells in fibrotic disease. Cell Stem Cell. 2017;21(2):166\u201377.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3782_CR12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1513\/pats.200601-012TK","volume":"3","author":"A Pardo","year":"2006","unstructured":"Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006;3(4):383\u20138.","journal-title":"Proc Am Thorac Soc"},{"key":"3782_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","volume":"24","author":"MO Li","year":"2006","unstructured":"Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99\u2013146.","journal-title":"Annu Rev Immunol"},{"key":"3782_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fmed.2015.00059","volume":"2","author":"B Piersma","year":"2015","unstructured":"Piersma B, Bank RA, Boersema M. Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ Converge. Front Med. 2015;2:59.","journal-title":"Front Med"},{"issue":"6","key":"3782_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3782_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128\u201339.","journal-title":"Cell Res"},{"issue":"1","key":"3782_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jss.2005.04.016","volume":"129","author":"RD Nagy","year":"2005","unstructured":"Nagy RD, Tsai BM, Wang M, Markel TA, Brown JW, Meldrum DR. Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res. 2005;129(1):152\u201360.","journal-title":"J Surg Res"},{"issue":"2","key":"3782_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","volume":"24","author":"JK Biehl","year":"2009","unstructured":"Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24(2):98.","journal-title":"J Cardiovasc Nurs"},{"issue":"5391","key":"3782_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"3","key":"3782_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1634\/stemcells.19-3-193","volume":"19","author":"JS Odorico","year":"2001","unstructured":"Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19(3):193\u2013204.","journal-title":"Stem Cells"},{"issue":"4","key":"3782_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"3782_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"5858","key":"3782_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"3","key":"3782_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/SHK.0b013e318285f2e2","volume":"39","author":"CK How","year":"2013","unstructured":"How CK, Chien Y, Yang KY, Shih HC, Juan CC, Yang YP, et al. Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin-induced lung inflammation and fibrosis. Shock. 2013;39(3):261\u201370.","journal-title":"Shock"},{"issue":"4","key":"3782_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12015-015-9587-7","volume":"11","author":"M Barczyk","year":"2015","unstructured":"Barczyk M, Schmidt M, Mattoli S. Stem cell-based therapy in idiopathic pulmonary fibrosis. Stem cell Reviews Rep. 2015;11(4):598\u2013620.","journal-title":"Stem cell Reviews Rep"},{"issue":"5411","key":"3782_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137.","journal-title":"Science"},{"issue":"10","key":"3782_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1172\/JCI0215182","volume":"109","author":"RE Schwartz","year":"2002","unstructured":"Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Investig. 2002;109(10):1291\u2013302.","journal-title":"J Clin Investig"},{"issue":"7","key":"3782_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.arth.2015.01.037","volume":"30","author":"L Yu","year":"2015","unstructured":"Yu L, Weng Y, Shui X, Fang W, Zhang E, Pan J. Multipotent adult progenitor cells from bone marrow differentiate into chondrocyte-like cells. J Arthroplast. 2015;30(7):1273\u20136.","journal-title":"J Arthroplast"},{"key":"3782_CR29","doi-asserted-by":"publisher","first-page":"8031718","DOI":"10.1155\/2018\/8031718","volume":"2018","author":"REB Fitzsimmons","year":"2018","unstructured":"Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA. Mesenchymal Stromal\/Stem cells in Regenerative Medicine and tissue Engineering. Stem Cells Int. 2018;2018:8031718.","journal-title":"Stem Cells Int"},{"key":"3782_CR30","unstructured":"Friedenstein A, AJ F. AF P. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. 1974."},{"issue":"6","key":"3782_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","volume":"10","author":"A Keating","year":"2012","unstructured":"Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709\u201316.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3782_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829\u201348.","journal-title":"Cell Transplant"},{"key":"3782_CR33","doi-asserted-by":"crossref","unstructured":"Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H et al. Mesenchymal stromal cell-based therapy: New perspectives and challenges. J Clin Med. 2019;8(5).","DOI":"10.3390\/jcm8050626"},{"issue":"6","key":"3782_CR34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/mt.2009.62","volume":"17","author":"DJ Prockop","year":"2009","unstructured":"Prockop DJ. Repair of tissues by adult stem\/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Therapy: J Am Soc Gene Therapy. 2009;17(6):939\u201346.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"10","key":"3782_CR35","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safe ty of cell therapy with mesenchymal stromal cells (safecell): a systematic review and meta-analysis of clinical trials. PLoS ONE. 2012;7(10):e47559.","journal-title":"PLoS ONE"},{"issue":"2","key":"3782_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/rej.2009.0830","volume":"12","author":"K Ksi\u0105\u017cek","year":"2009","unstructured":"Ksi\u0105\u017cek K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuven Res. 2009;12(2):105\u201316.","journal-title":"Rejuven Res"},{"issue":"1","key":"3782_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00383-009-2478-8","volume":"26","author":"M Pozzobon","year":"2010","unstructured":"Pozzobon M, Ghionzoli M, De Coppi P. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric surgery: current research and perspective. Pediatr Surg Int. 2010;26(1):3\u201310.","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"3782_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13287-021-02469-5","volume":"12","author":"Z Tang","year":"2021","unstructured":"Tang Z, Gao J, Wu J, Zeng G, Liao Y, Song Z, et al. Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage. Stem Cell Res Ther. 2021;12(1):397.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3782_CR39","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ajpath.2014.01.012","volume":"184","author":"H Xia","year":"2014","unstructured":"Xia H, Bodempudi V, Benyumov A, Hergert P, Tank D, Herrera J, et al. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. Am J Pathol. 2014;184(5):1369\u201383.","journal-title":"Am J Pathol"},{"issue":"4","key":"3782_CR40","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5(4):e10088.","journal-title":"PLoS ONE"},{"issue":"13","key":"3782_CR41","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","volume":"106","author":"N Eliopoulos","year":"2005","unstructured":"Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood. 2005;106(13):4057\u201365.","journal-title":"Blood"},{"issue":"4","key":"3782_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbmt.2006.12.447","volume":"13","author":"AT Badillo","year":"2007","unstructured":"Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW. Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant. 2007;13(4):412\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"3782_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/icb.2012.67","volume":"91","author":"MD Griffin","year":"2013","unstructured":"Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol. 2013;91(1):40\u201351.","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"3782_CR44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.4049\/jimmunol.179.3.1549","volume":"179","author":"R Romieu-Mourez","year":"2007","unstructured":"Romieu-Mourez R, Fran\u00e7ois M, Boivin MN, Stagg J, Galipeau J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol (Baltimore Md: 1950). 2007;179(3):1549\u201358.","journal-title":"J Immunol (Baltimore Md: 1950)"},{"issue":"11","key":"3782_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.exphem.2008.06.008","volume":"36","author":"WK Chan","year":"2008","unstructured":"Chan WK, Lau AS, Li JC, Law HK, Lau YL, Chan GC. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Exp Hematol. 2008;36(11):1545\u201355.","journal-title":"Exp Hematol"},{"issue":"12","key":"3782_CR46","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1002\/art.10696","volume":"46","author":"EA Jones","year":"2002","unstructured":"Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002;46(12):3349\u201360.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3782_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/scrt402","volume":"5","author":"LV Schnabel","year":"2014","unstructured":"Schnabel LV, Pezzanite LM, Antczak DF, Felippe MJ, Fortier LA. Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro. Stem Cell Res Ther. 2014;5(1):13.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/sci.2019.06.09","volume":"6","author":"Q Lu","year":"2019","unstructured":"Lu Q, El-Hashash AHK. Cell-based therapy for idiopathic pulmonary fibrosis. Stem cell Invest. 2019;6:22.","journal-title":"Stem cell Invest"},{"issue":"9","key":"3782_CR49","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.exphem.2007.05.012","volume":"35","author":"X Yan","year":"2007","unstructured":"Yan X, Liu Y, Han Q, Jia M, Liao L, Qi M, et al. Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp Hematol. 2007;35(9):1466\u201375.","journal-title":"Exp Hematol"},{"key":"3782_CR50","first-page":"477","volume":"9","author":"S Yang","year":"2021","unstructured":"Yang S, Liu P, Jiang Y, Wang Z, Dai H, Wang C. Therapeutic applications of mesenchymal stem cells in idiopathic pulmonary fibrosis. Front Cell Dev Biology. 2021;9:477.","journal-title":"Front Cell Dev Biology"},{"issue":"6","key":"3782_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/jcb.24783","volume":"115","author":"MA Antunes","year":"2014","unstructured":"Antunes MA, Laffey JG, Pelosi P, Rocco PR. Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem. 2014;115(6):1023\u201332.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3782_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12931-014-0118-x","volume":"15","author":"MA Antunes","year":"2014","unstructured":"Antunes MA, Abreu SC, Cruz FF, Teixeira AC, Lopes-Pacheco M, Bandeira E, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res. 2014;15(1):118.","journal-title":"Respir Res"},{"issue":"2","key":"3782_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/cea.13048","volume":"48","author":"JZ Kitoko","year":"2018","unstructured":"Kitoko JZ, de Castro LL, Nascimento AP, Abreu SC, Cruz FF, Arantes AC, et al. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma. Clin Experimental Allergy: J Br Soc Allergy Clin Immunol. 2018;48(2):205\u201316.","journal-title":"Clin Experimental Allergy: J Br Soc Allergy Clin Immunol"},{"issue":"1","key":"3782_CR54","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11033-018-04582-w","volume":"46","author":"M El-Sayed","year":"2019","unstructured":"El-Sayed M, El-Feky MA, El-Amir MI, Hasan AS, Tag-Adeen M, Urata Y, et al. Immunomodulatory effect of mesenchymal stem cells: cell origin and cell quality variations. Mol Biol Rep. 2019;46(1):1157\u201365.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3782_CR55","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1038\/s41598-020-61167-z","volume":"10","author":"Y Petrenko","year":"2020","unstructured":"Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K, et al. A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Sci Rep. 2020;10(1):4290.","journal-title":"Sci Rep"},{"issue":"2","key":"3782_CR56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1165\/rcmb.2002-0069OC","volume":"29","author":"MW Epperly","year":"2003","unstructured":"Epperly MW, Guo H, Gretton JE, Greenberger JS. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29(2):213\u201324.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3782_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10753-019-01101-2","volume":"43","author":"ES Gad","year":"2020","unstructured":"Gad ES, Salama AAA, El-Shafie MF, Arafa HMM, Abdelsalam RM, Khattab M. The anti-fibrotic and anti-inflammatory potential of bone marrow-derived mesenchymal stem cells and Nintedanib in Bleomycin-Induced lung fibrosis in rats. Inflammation. 2020;43(1):123\u201334.","journal-title":"Inflammation"},{"issue":"8","key":"3782_CR58","doi-asserted-by":"publisher","first-page":"e69299","DOI":"10.1371\/journal.pone.0069299","volume":"8","author":"Y Moodley","year":"2013","unstructured":"Moodley Y, Vaghjiani V, Chan J, Baltic S, Ryan M, Tchongue J, et al. Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study. PLoS ONE. 2013;8(8):e69299.","journal-title":"PLoS ONE"},{"issue":"1","key":"3782_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13287-018-0981-3","volume":"9","author":"B Antebi","year":"2018","unstructured":"Antebi B, Walker KP 3rd, Mohammadipoor A, Rodriguez LA, Montgomery RK, Batchinsky AI, et al. The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):251.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3782_CR60","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kl\u00fcter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"3","key":"3782_CR61","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jcyt.2012.11.010","volume":"15","author":"MS Choudhery","year":"2013","unstructured":"Choudhery MS, Badowski M, Muise A, Harris DT. Comparison of human mesenchymal stem cells derived from adipose and cord tissue. Cytotherapy. 2013;15(3):330\u201343.","journal-title":"Cytotherapy"},{"key":"3782_CR62","doi-asserted-by":"crossref","unstructured":"Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. Journal of immunology (Baltimore, Md: 1950). 2004;172(2):1266-72.","DOI":"10.4049\/jimmunol.172.2.1266"},{"issue":"2","key":"3782_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","volume":"33","author":"M Rojas","year":"2005","unstructured":"Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, et al. Bone marrow\u2013derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005;33(2):145\u201352.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"14","key":"3782_CR64","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"LA Ortiz","year":"2003","unstructured":"Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100(14):8407\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3782_CR65","doi-asserted-by":"publisher","first-page":"e65453","DOI":"10.1371\/journal.pone.0065453","volume":"8","author":"A Gazdhar","year":"2013","unstructured":"Gazdhar A, Susuri N, Hostettler K, Gugger M, Knudsen L, Roth M, et al. HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic. PLoS ONE. 2013;8(6):e65453.","journal-title":"PLoS ONE"},{"issue":"3","key":"3782_CR66","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2014.2981","volume":"11","author":"K Huang","year":"2015","unstructured":"Huang K, Kang X, Wang X, Wu S, Xiao J, Li Z, et al. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats. Mol Med Rep. 2015;11(3):1685\u201392.","journal-title":"Mol Med Rep"},{"issue":"1","key":"3782_CR67","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-018-0970-6","volume":"9","author":"N C\u00e1rdenes","year":"2018","unstructured":"C\u00e1rdenes N, \u00c1lvarez D, Sellar\u00e9s J, Peng Y, Corey C, Wecht S, et al. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis. Stem Cell Res Ther. 2018;9(1):257.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR68","doi-asserted-by":"crossref","unstructured":"Campo A, Gonz\u00e1lez-Ruiz JM, Andreu E, Alcaide AB, Oc\u00f3n MM, De-Torres J et al. Endobronchial autologous bone marrow-mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial. ERJ open Res. 2021;7(2).","DOI":"10.1183\/23120541.00773-2020"},{"issue":"1","key":"3782_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s13287-021-02429-z","volume":"12","author":"H Tang","year":"2021","unstructured":"Tang H, Zhang P, Zeng L, Zhao Y, Xie L, Chen B. Mesenchymal stem cells ameliorate renal fibrosis by galectin-3\/Akt\/GSK3\u03b2\/Snail signaling pathway in adenine-induced nephropathy rat. Stem Cell Res Ther. 2021;12(1):409.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"3782_CR70","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jcyt.2016.05.004","volume":"18","author":"HH Anan","year":"2016","unstructured":"Anan HH, Zidan RA, Shaheen MA, Abd-El Fattah EA. Therapeutic efficacy of bone marrow derived mesenchymal stromal cells versus losartan on adriamycin-induced renal cortical injury in adult albino rats. Cytotherapy. 2016;18(8):970\u201384.","journal-title":"Cytotherapy"},{"issue":"6","key":"3782_CR71","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jcyt.2014.01.004","volume":"16","author":"R Moghadasali","year":"2014","unstructured":"Moghadasali R, Azarnia M, Hajinasrollah M, Arghani H, Nassiri SM, Molazem M, et al. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus macaque mulatta monkey model. Cytotherapy. 2014;16(6):734\u201349.","journal-title":"Cytotherapy"},{"issue":"12","key":"3782_CR72","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3727\/096368915X687534","volume":"24","author":"AF da Silva","year":"2015","unstructured":"da Silva AF, Silva K, Reis LA, Teixeira VP, Schor N. Bone marrow-derived mesenchymal stem cells and their conditioned medium Attenuate Fibrosis in an irreversible model of unilateral ureteral obstruction. Cell Transpl. 2015;24(12):2657\u201366.","journal-title":"Cell Transpl"},{"issue":"4","key":"3782_CR73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/term.2607","volume":"12","author":"A Despeyroux","year":"2018","unstructured":"Despeyroux A, Duret C, Gondeau C, Perez-Gracia E, Chuttoo L, de Boussac H, et al. Mesenchymal stem cells seeded on a human amniotic membrane improve liver regeneration and mouse survival after extended hepatectomy. J Tissue Eng Regen Med. 2018;12(4):1062\u201373.","journal-title":"J Tissue Eng Regen Med"},{"issue":"5","key":"3782_CR74","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/gutjnl-2015-311146","volume":"66","author":"D Shi","year":"2017","unstructured":"Shi D, Zhang J, Zhou Q, Xin J, Jiang J, Jiang L, et al. Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs. Gut. 2017;66(5):955\u201364.","journal-title":"Gut"},{"issue":"6","key":"3782_CR75","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, Yoon JH, Kim MY, Kim CW, Kim JK, Park H, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology (Baltimore MD). 2016;64(6):2185\u201397.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"10","key":"3782_CR76","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.12228","volume":"33","author":"M Mohamadnejad","year":"2013","unstructured":"Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver International: Official J Int Association Study Liver. 2013;33(10):1490\u20136.","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"3782_CR77","first-page":"51","volume":"698","author":"A Can","year":"2011","unstructured":"Can A, Balci D. Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells. (Clifton NJ). 2011;698:51\u201362. Methods in molecular biology.","journal-title":"(Clifton NJ)"},{"issue":"3","key":"3782_CR78","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3727\/096368912X655064","volume":"22","author":"AN Patel","year":"2013","unstructured":"Patel AN, Vargas V, Revello P, Bull DA. Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue. Cell Transplant. 2013;22(3):513\u20139.","journal-title":"Cell Transplant"},{"issue":"6","key":"3782_CR79","doi-asserted-by":"publisher","first-page":"e0196048","DOI":"10.1371\/journal.pone.0196048","volume":"13","author":"G Moroncini","year":"2018","unstructured":"Moroncini G, Paolini C, Orlando F, Capelli C, Grieco A, Tonnini C, et al. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice. PLoS ONE. 2018;13(6):e0196048.","journal-title":"PLoS ONE"},{"issue":"5","key":"3782_CR80","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.3892\/etm.2017.4222","volume":"13","author":"C Zhang","year":"2017","unstructured":"Zhang C, Yin X, Zhang J, Ao Q, Gu Y, Liu Y. Clinical observation of umbilical cord mesenchymal stem cell treatment of severe idiopathic pulmonary fibrosis: a case report. Experimental Therapeutic Med. 2017;13(5):1922\u20136.","journal-title":"Experimental Therapeutic Med"},{"issue":"1\u20132","key":"3782_CR81","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-017-2940-1","volume":"429","author":"J Xuan","year":"2017","unstructured":"Xuan J, Feng W, An ZT, Yang J, Xu HB, Li J, et al. Anti-TGF\u03b2-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGF\u03b2-1\/Smad pathway. Mol Cell Biochem. 2017;429(1\u20132):113\u201322.","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"3782_CR82","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev"},{"issue":"Suppl 2","key":"3782_CR83","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","volume":"27","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27(Suppl 2):112\u201320.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"3782_CR84","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J, Verdugo FJ, Gonz\u00e1lez PL, Larrea RE, Abarzua E, Goset C, et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circul Res. 2017;121(10):1192\u2013204.","journal-title":"Circul Res"},{"issue":"9","key":"3782_CR85","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3727\/096368915X690314","volume":"25","author":"J Tuma","year":"2016","unstructured":"Tuma J, Carrasco A, Castillo J, Cruz C, Carrillo A, Ercilla J, et al. RESCUE-HF trial: retrograde delivery of allogeneic umbilical cord lining subepithelial cells in patients with heart failure. Cell Transplant. 2016;25(9):1713\u201321.","journal-title":"Cell Transplant"},{"key":"3782_CR86","doi-asserted-by":"crossref","unstructured":"Liang B, Chen J, Li T, Wu H, Yang W, Li Y et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report. Medicine. 2020;99(31).","DOI":"10.1097\/MD.0000000000021429"},{"key":"3782_CR87","unstructured":"Lanzoni G, Linetsky E, Correa D, Alvarez RA, Marttos A, Hirani K et al. Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS). CellR4\u2013 repair, replacement, regeneration, & reprogramming. 2020;8."},{"key":"3782_CR88","doi-asserted-by":"crossref","unstructured":"Afarid M, Sanie-Jahromi F. Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination. Stem cells international. 2021;2021.","DOI":"10.1155\/2021\/6666370"},{"key":"3782_CR89","doi-asserted-by":"crossref","unstructured":"Lu Q, El-Hashash AH. Cell-based therapy for idiopathic pulmonary fibrosis. Stem cell Invest. 2019;6.","DOI":"10.21037\/sci.2019.06.09"},{"issue":"4","key":"3782_CR90","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3727\/096368909788809857","volume":"18","author":"A Cargnoni","year":"2009","unstructured":"Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, Arienti D, et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant. 2009;18(4):405\u201322.","journal-title":"Cell Transplant"},{"key":"3782_CR91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molimm.2017.06.032","volume":"90","author":"F Li","year":"2017","unstructured":"Li F, Han F, Li H, Zhang J, Qiao X, Shi J, et al. Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice. Mol Immunol. 2017;90:11\u201321.","journal-title":"Mol Immunol"},{"issue":"7","key":"3782_CR92","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/resp.12343","volume":"19","author":"DC Chambers","year":"2014","unstructured":"Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirol (Carlton Vic). 2014;19(7):1013\u20138.","journal-title":"Respirol (Carlton Vic)"},{"issue":"4","key":"3782_CR93","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1574888X0904140429142451","volume":"9","author":"A Carbone","year":"2014","unstructured":"Carbone A, Paracchini V, Castellani S, Di Gioia S, Seia M, Colombo C, et al. Human amnion-derived cells: prospects for the treatment of lung diseases. Curr Stem Cell Res Therapy. 2014;9(4):297\u2013305.","journal-title":"Curr Stem Cell Res Therapy"},{"key":"3782_CR94","doi-asserted-by":"publisher","first-page":"3212643","DOI":"10.1155\/2018\/3212643","volume":"2018","author":"M Ohara","year":"2018","unstructured":"Ohara M, Ohnishi S, Hosono H, Yamamoto K, Yuyama K, Nakamura H, et al. Extracellular vesicles from Amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats. Stem Cells Int. 2018;2018:3212643.","journal-title":"Stem Cells Int"},{"issue":"10","key":"3782_CR95","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1111\/liv.14610","volume":"40","author":"G Pietrosi","year":"2020","unstructured":"Pietrosi G, Fern\u00e1ndez-Iglesias A, Pampalone M, Ortega-Ribera M, Lozano JJ, Garc\u00eda-Calder\u00f3 H, et al. Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats. Liver International: Official J Int Association Study Liver. 2020;40(10):2500\u201314.","journal-title":"Liver International: Official J Int Association Study Liver"},{"issue":"9","key":"3782_CR96","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","volume":"100","author":"JM Gimble","year":"2007","unstructured":"Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249\u201360.","journal-title":"Circ Res"},{"issue":"5","key":"3782_CR97","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MCP.0b013e328348744f","volume":"17","author":"A Tzouvelekis","year":"2011","unstructured":"Tzouvelekis A, Antoniadis A, Bouros D. Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med. 2011;17(5):368\u201373.","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"3782_CR98","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10561-017-9674-x","volume":"19","author":"S Sabetkish","year":"2018","unstructured":"Sabetkish S, Sabetkish N, Talebi MA, Halimi S, Kajbafzadeh AM. The role of nonautologous and autologous adipose-derived mesenchymal stem cell in acute pyelonephritis. Cell Tissue Banking. 2018;19(3):301\u20139.","journal-title":"Cell Tissue Banking"},{"issue":"3","key":"3782_CR99","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/01902148.2014.881930","volume":"40","author":"SH Lee","year":"2014","unstructured":"Lee SH, Lee EJ, Lee SY, Kim JH, Shim JJ, Shin C, et al. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice. Exp Lung Res. 2014;40(3):117\u201325.","journal-title":"Exp Lung Res"},{"issue":"1","key":"3782_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15022-3","volume":"7","author":"T Kotani","year":"2017","unstructured":"Kotani T, Masutani R, Suzuka T, Oda K, Makino S, Ii M. Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia. Sci Rep. 2017;7(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"2","key":"3782_CR101","doi-asserted-by":"publisher","first-page":"192","DOI":"10.15283\/ijsc16041","volume":"9","author":"M Reddy","year":"2016","unstructured":"Reddy M, Fonseca L, Gowda S, Chougule B, Hari A, Totey S. Human adipose-derived mesenchymal stem cells attenuate early stage of bleomycin induced pulmonary fibrosis: comparison with pirfenidone. Int J stem Cells. 2016;9(2):192.","journal-title":"Int J stem Cells"},{"issue":"1","key":"3782_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-018-0846-9","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, et al. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018;9(1):1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3782_CR103","first-page":"5956","volume":"14","author":"T Hao","year":"2017","unstructured":"Hao T, Chen J, Zhi S, Zhang Q, Chen G, Yu F. Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis. Exp Ther Med. 2017;14(6):5956\u201364.","journal-title":"Exp Ther Med"},{"issue":"1","key":"3782_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu C, Zhao L, Li L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther. 2019;10(1):1\u201313.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3782_CR105","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SAP.0000000000001278","volume":"80","author":"AA Borovikova","year":"2018","unstructured":"Borovikova AA, Ziegler ME, Banyard DA, Wirth GA, Paydar KZ, Evans GRD, et al. Adipose-derived tissue in the treatment of dermal fibrosis: Antifibrotic effects of adipose-derived stem cells. Ann Plast Surg. 2018;80(3):297\u2013307.","journal-title":"Ann Plast Surg"},{"issue":"1","key":"3782_CR106","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13287-016-0356-6","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Zhang W, Gao J, Liu J, Wang H, Li J, et al. Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38\/MAPK signaling pathway. Stem Cell Res Ther. 2016;7(1):102.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"3782_CR107","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/sctm.19-0317","volume":"9","author":"MR Borrelli","year":"2020","unstructured":"Borrelli MR, Patel RA, Adem S, Diaz Deleon NM, Shen AH, Sokol J, et al. The antifibrotic adipose-derived stromal cell: grafted fat enriched with CD74\u2009+\u2009adipose-derived stromal cells reduces chronic radiation-induced skin fibrosis. Stem Cells Translational Med. 2020;9(11):1401\u201313.","journal-title":"Stem Cells Translational Med"},{"key":"3782_CR108","doi-asserted-by":"crossref","unstructured":"Uji M, Nakada A, Nakamura T. Intravenous administration of adipose-derived stromal cells does not ameliorate bleomycin-induced lung injury in rats. 2013.","DOI":"10.4236\/ojrm.2013.22007"},{"issue":"2","key":"3782_CR109","first-page":"81","volume":"61","author":"M Uji","year":"2015","unstructured":"Uji M, Nakada A, Nakamura T, Hirata K. Effect of Intratracheal Administration of adipose-derived stromal cells on bleomycin-induced Lung Injury in a rat model. Osaka City Med J. 2015;61(2):81\u201391.","journal-title":"Osaka City Med J"},{"issue":"6","key":"3782_CR110","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.trsl.2015.09.004","volume":"166","author":"J Tashiro","year":"2015","unstructured":"Tashiro J, Elliot SJ, Gerth DJ, Xia X, Pereira-Simon S, Choi R, et al. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Translational Research: J Lab Clin Med. 2015;166(6):554\u201367.","journal-title":"Translational Research: J Lab Clin Med"},{"issue":"08","key":"3782_CR111","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2217\/rme-2020-0068","volume":"15","author":"D Ilic","year":"2020","unstructured":"Ilic D, Liovic M. Industry updates from the field of stem cell research and regenerative medicine in April 2020. Regen Med. 2020;15(08):1943\u201350.","journal-title":"Regen Med"},{"key":"3782_CR112","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.intimp.2017.01.008","volume":"44","author":"Y Song","year":"2017","unstructured":"Song Y, Peng C, Lv S, Cheng J, Liu S, Wen Q, et al. Adipose-derived stem cells ameliorate renal interstitial fibrosis through inhibition of EMT and inflammatory response via TGF-\u03b21 signaling pathway. Int Immunopharmacol. 2017;44:115\u201322.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"3782_CR113","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3727\/096368911X623925","volume":"21","author":"C Donizetti-Oliveira","year":"2012","unstructured":"Donizetti-Oliveira C, Semedo P, Burgos-Silva M, Cenedeze MA, Malheiros DM, Reis MA, et al. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transpl. 2012;21(8):1727\u201341.","journal-title":"Cell Transpl"},{"issue":"1","key":"3782_CR114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4252\/wjsc.v7.i1.165","volume":"7","author":"LS Baptista","year":"2015","unstructured":"Baptista LS, Silva KR, Borojevic R. Obesity and weight loss could alter the properties of adipose stem cells? World J stem Cells. 2015;7(1):165\u201373.","journal-title":"World J stem Cells"},{"key":"3782_CR115","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1741-7015-11-146","volume":"11","author":"G Siegel","year":"2013","unstructured":"Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Sch\u00e4fer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 2013;11:146.","journal-title":"BMC Med"},{"issue":"6","key":"3782_CR116","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.blre.2005.01.005","volume":"19","author":"PH Lerou","year":"2005","unstructured":"Lerou PH, Daley GQ. Therapeutic potential of embryonic stem cells. Blood Rev. 2005;19(6):321\u201331.","journal-title":"Blood Rev"},{"key":"3782_CR117","doi-asserted-by":"crossref","unstructured":"Tzukerman M, Rosenberg T, Ravel Y, Reiter I, Coleman R, Skorecki K. An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proceedings of the National Academy of Sciences. 2003;100(23):13507-12.","DOI":"10.1073\/pnas.2235551100"},{"issue":"1","key":"3782_CR118","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2","volume":"257","author":"KS O\u2019Shea","year":"1999","unstructured":"O\u2019Shea KS. Embryonic stem cell models of development. Anat Record: Official Publication Am Association Anatomists. 1999;257(1):32\u201341.","journal-title":"Anat Record: Official Publication Am Association Anatomists"},{"key":"3782_CR119","first-page":"S83","volume":"7","author":"JS Lebkowski","year":"2001","unstructured":"Lebkowski JS, Gold J, Xu C, Funk W, Chiu C-P, Carpenter MK. Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications. Cancer J (Sudbury Mass). 2001;7:S83\u201393.","journal-title":"Cancer J (Sudbury Mass)"},{"issue":"2","key":"3782_CR120","doi-asserted-by":"publisher","first-page":"H1308","DOI":"10.1152\/ajpheart.01277.2006","volume":"293","author":"DK Singla","year":"2007","unstructured":"Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol. 2007;293(2):H1308\u201314.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"3782_CR121","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1183\/09031936.00005511","volume":"39","author":"P Spitalieri","year":"2012","unstructured":"Spitalieri P, Quitadamo MC, Orlandi A, Guerra L, Giardina E, Casavola V, et al. Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells. Eur Respir J. 2012;39(2):446\u201357.","journal-title":"Eur Respir J"},{"issue":"3","key":"3782_CR122","doi-asserted-by":"publisher","first-page":"e33165","DOI":"10.1371\/journal.pone.0033165","volume":"7","author":"ER Banerjee","year":"2012","unstructured":"Banerjee ER, Laflamme MA, Papayannopoulou T, Kahn M, Murry CE, Henderson WR. Jr. Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS ONE. 2012;7(3):e33165.","journal-title":"PLoS ONE"},{"issue":"9","key":"3782_CR123","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41422-020-0354-1","volume":"30","author":"J Wu","year":"2020","unstructured":"Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30(9):794\u2013809.","journal-title":"Cell Res"},{"issue":"1","key":"3782_CR124","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-023-03449-7","volume":"14","author":"Q Liu","year":"2023","unstructured":"Liu Q, Bi Y, Song S, Zhu K, Qiao X, Wang H, et al. Exosomal mir-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2. Stem Cell Res Ther. 2023;14(1):234.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3782_CR125","doi-asserted-by":"publisher","first-page":"880","DOI":"10.4161\/cc.9.5.10827","volume":"9","author":"N Sun","year":"2010","unstructured":"Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: considerations before clinical applications. Cell Cycle (Georgetown Tex). 2010;9(5):880\u20135.","journal-title":"Cell Cycle (Georgetown Tex)"},{"issue":"1","key":"3782_CR126","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00383-009-2478-8","volume":"26","author":"M Pozzobon","year":"2010","unstructured":"Pozzobon M, Ghionzoli M, De Coppi PES. iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric surgery: current research and perspective. Pediatr Surg Int. 2010;26(1):3.","journal-title":"Pediatr Surg Int"},{"issue":"4","key":"3782_CR127","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","volume":"12","author":"P Guha","year":"2013","unstructured":"Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell. 2013;12(4):407\u201312.","journal-title":"Cell Stem Cell"},{"issue":"7435","key":"3782_CR128","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11807","volume":"494","author":"R Araki","year":"2013","unstructured":"Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. 2013;494(7435):100\u20134.","journal-title":"Nature"},{"issue":"4","key":"3782_CR129","doi-asserted-by":"publisher","first-page":"e10192","DOI":"10.1371\/journal.pone.0010192","volume":"5","author":"B Su\u00e1rez-Alvarez","year":"2010","unstructured":"Su\u00e1rez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, Ortega F, et al. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS ONE. 2010;5(4):e10192.","journal-title":"PLoS ONE"},{"issue":"5","key":"3782_CR130","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3727\/096368913X674639","volume":"24","author":"HF Chen","year":"2015","unstructured":"Chen HF, Yu CY, Chen MJ, Chou SH, Chiang MS, Chou WH, et al. Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives. Cell Transplant. 2015;24(5):845\u201364.","journal-title":"Cell Transplant"},{"issue":"6","key":"3782_CR131","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00281-011-0265-9","volume":"33","author":"S Kadereit","year":"2011","unstructured":"Kadereit S, Trounson A. In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. Semin Immunopathol. 2011;33(6):551\u201362.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"3782_CR132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.stem.2013.03.008","volume":"12","author":"S Kaneko","year":"2013","unstructured":"Kaneko S, Yamanaka S. To be immunogenic, or not to be: that\u2019s the iPSC question. Cell Stem Cell. 2013;12(4):385\u20136.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3782_CR133","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2217\/rme.14.29","volume":"9","author":"LV Schnabel","year":"2014","unstructured":"Schnabel LV, Abratte CM, Schimenti JC, Felippe MJ, Cassano JM, Southard TL, et al. Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro. Regen Med. 2014;9(5):621\u201335.","journal-title":"Regen Med"},{"issue":"10","key":"3782_CR134","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/nbt1335","volume":"25","author":"A Meissner","year":"2007","unstructured":"Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007;25(10):1177\u201381.","journal-title":"Nat Biotechnol"},{"issue":"26","key":"3782_CR135","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1016\/j.biomaterials.2011.05.009","volume":"32","author":"HY Li","year":"2011","unstructured":"Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, Chiang CH, et al. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials. 2011;32(26):5994\u20136005.","journal-title":"Biomaterials"},{"issue":"5903","key":"3782_CR136","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1164270","volume":"322","author":"K Okita","year":"2008","unstructured":"Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008;322(5903):949\u201353.","journal-title":"Science"},{"issue":"5","key":"3782_CR137","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8(5):409\u201312.","journal-title":"Nat Methods"},{"issue":"8","key":"3782_CR138","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Japan Acad Ser B Phys Biol Sci. 2009;85(8):348\u201362.","journal-title":"Proc Japan Acad Ser B Phys Biol Sci"},{"issue":"5","key":"3782_CR139","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136(5):964\u201377.","journal-title":"Cell"},{"issue":"5","key":"3782_CR140","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","volume":"4","author":"H Zhou","year":"2009","unstructured":"Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4(5):381\u20134.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"3782_CR141","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7(5):618\u201330.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3782_CR142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12015-016-9680-6","volume":"13","author":"M Yoshihara","year":"2017","unstructured":"Yoshihara M, Hayashizaki Y, Murakawa Y. Genomic instability of iPSCs: challenges towards their clinical applications. Stem cell Reviews Rep. 2017;13(1):7\u201316.","journal-title":"Stem cell Reviews Rep"},{"issue":"1","key":"3782_CR143","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1172\/JCI40553","volume":"120","author":"E Kiskinis","year":"2010","unstructured":"Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Investig. 2010;120(1):51\u20139.","journal-title":"J Clin Investig"},{"key":"3782_CR144","doi-asserted-by":"crossref","unstructured":"Pareja E, G\u00f3mez-Lech\u00f3n MJ, Tolosa L. Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint. Annals Translational Med. 2020;8(8).","DOI":"10.21037\/atm.2020.02.164"},{"issue":"1","key":"3782_CR145","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/0471142727.mb3101s107","volume":"107","author":"L Yang","year":"2014","unstructured":"Yang L, Yang JL, Byrne S, Pan J, Church GM. CRISPR\/Cas9-directed genome editing of cultured cells. Curr Protoc Mol Biol. 2014;107(1):31. 1-.1. 17.","journal-title":"Curr Protoc Mol Biol"},{"issue":"1","key":"3782_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep08826","volume":"5","author":"B Imberti","year":"2015","unstructured":"Imberti B, Tomasoni S, Ciampi O, Pezzotta A, Derosas M, Xinaris C, et al. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci Rep. 2015;5(1):1\u20137.","journal-title":"Sci Rep"},{"issue":"1","key":"3782_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-89550-4","volume":"11","author":"V Chandrasekaran","year":"2021","unstructured":"Chandrasekaran V, Carta G, da Costa Pereira D, Gupta R, Murphy C, Feifel E, et al. Generation and characterization of iPSC-derived renal proximal tubule-like cells with extended stability. Sci Rep. 2021;11(1):1\u201317.","journal-title":"Sci Rep"},{"issue":"2","key":"3782_CR148","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/jid.2012.278","volume":"133","author":"J Tolar","year":"2013","unstructured":"Tolar J, Xia L, Lees CJ, Riddle M, McElroy A, Keene DR, et al. Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol. 2013;133(2):562\u20135.","journal-title":"J Invest Dermatol"},{"issue":"21","key":"3782_CR149","doi-asserted-by":"publisher","first-page":"8797","DOI":"10.1073\/pnas.1100332108","volume":"108","author":"M Itoh","year":"2011","unstructured":"Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA. 2011;108(21):8797\u2013802.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3782_CR150","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1073\/pnas.1201753109","volume":"110","author":"R Shalom-Feuerstein","year":"2013","unstructured":"Shalom-Feuerstein R, Serror L, Aberdam E, M\u00fcller FJ, van Bokhoven H, Wiman KG, et al. Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246\/PRIMA-1MET. Proc Natl Acad Sci USA. 2013;110(6):2152\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"239","key":"3782_CR151","doi-asserted-by":"publisher","first-page":"ps2396","DOI":"10.1126\/scitranslmed.3008921","volume":"6","author":"E Matsa","year":"2014","unstructured":"Matsa E, Burridge PW, Wu JC. Human stem cells for modeling heart disease and for drug discovery. Sci Transl Med. 2014;6(239):ps2396\u20136.","journal-title":"Sci Transl Med"},{"key":"3782_CR152","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fmed.2019.00265","volume":"6","author":"JL Corbett","year":"2019","unstructured":"Corbett JL, Duncan SA. iPSC-derived hepatocytes as a platform for disease modeling and drug discovery. Front Med. 2019;6:265.","journal-title":"Front Med"},{"issue":"7615","key":"3782_CR153","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature17982","volume":"536","author":"M Takasato","year":"2016","unstructured":"Takasato M, Pei XE, Chiu HS, Maier B, Baillie GJ, Ferguson C, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2016;536(7615):238.","journal-title":"Nature"},{"key":"3782_CR154","doi-asserted-by":"crossref","unstructured":"Osafune K. iPSC technology-based regenerative medicine for kidney diseases. Clin Exp Nephrol. 2021:1\u201311.","DOI":"10.1007\/s10157-021-02030-x"},{"issue":"3","key":"3782_CR155","first-page":"263","volume":"21","author":"P Bayati","year":"2022","unstructured":"Bayati P, Taherian M, Assarehzadegan MA, Soleimani M, Poormoghim H, Mojtabavi N. Induced Pluripotent stem-cells inhibit experimental bleomycin-induced pulmonary fibrosis through regulation of the insulin-like growth factor signaling. Iran J Allergy Asthma Immunol. 2022;21(3):263\u201372.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"3782_CR156","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphar.2016.00430","volume":"7","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, He Z, Gao Y, Zheng R, Zhang X, Zhao L, et al. Induced Pluripotent stem cells inhibit Bleomycin-Induced Pulmonary Fibrosis in mice through suppressing TGF-\u03b21\/Smad-Mediated epithelial to mesenchymal transition. Front Pharmacol. 2016;7:430.","journal-title":"Front Pharmacol"},{"key":"3782_CR157","doi-asserted-by":"crossref","unstructured":"Caldas HC, Lojudice FH, Dias C, Fernandes-Charpiot IMM, Baptista MASF, Kawasaki-Oyama RS et al. Induced pluripotent stem cells reduce progression of experimental chronic kidney disease but develop Wilms\u2019 tumors. Stem cells international. 2017;2017.","DOI":"10.1155\/2017\/7428316"},{"issue":"1","key":"3782_CR158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"P de Carvalho Ribeiro","year":"2020","unstructured":"de Carvalho Ribeiro P, Lojudice FH, Fernandes-Charpiot IMM, Baptista MASF, de Almeida Ara\u00fajo S, Mendes GEF, et al. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Stem Cell Res Ther. 2020;11(1):1\u201310.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3782_CR159","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nprot.2015.021","volume":"10","author":"AP Wong","year":"2015","unstructured":"Wong AP, Chin S, Xia S, Garner J, Bear CE, Rossant J. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc. 2015;10(3):363\u201381.","journal-title":"Nat Protoc"},{"issue":"4","key":"3782_CR160","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.stem.2017.08.014","volume":"21","author":"A Jacob","year":"2017","unstructured":"Jacob A, Morley M, Hawkins F, McCauley KB, Jean J, Heins H, et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell. 2017;21(4):472\u201388. e10.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"3782_CR161","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biomaterials.2013.10.018","volume":"35","author":"M Ghaedi","year":"2014","unstructured":"Ghaedi M, Mendez JJ, Bove PF, Sivarapatna A, Raredon MSB, Niklason LE. Alveolar epithelial differentiation of human induced pluripotent stem cells in a rotating bioreactor. Biomaterials. 2014;35(2):699\u2013710.","journal-title":"Biomaterials"},{"issue":"6","key":"3782_CR162","doi-asserted-by":"publisher","first-page":"675","DOI":"10.5966\/sctm.2013-0142","volume":"3","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Ye X, Sun R, Matsumoto Y, Moriyama M, Asano Y, et al. Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo. Stem Cells Translational Med. 2014;3(6):675\u201385.","journal-title":"Stem Cells Translational Med"},{"issue":"1","key":"3782_CR163","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-020-01726-3","volume":"11","author":"B Alvarez-Palomo","year":"2020","unstructured":"Alvarez-Palomo B, Sanchez-Lopez LI, Moodley Y, Edel MJ, Serrano-Mollar A. Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis. Stem Cell Res Ther. 2020;11(1):213.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"3782_CR164","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1038\/mt.2012.182","volume":"20","author":"BS Soh","year":"2012","unstructured":"Soh BS, Zheng D, Li Yeo JS, Yang HH, Ng SY, Wong LH, et al. CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury. Mol Therapy: J Am Soc Gene Therapy. 2012;20(12):2335\u201346.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"issue":"5","key":"3782_CR165","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ncb2239","volume":"13","author":"Y Ohi","year":"2011","unstructured":"Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol. 2011;13(5):541\u20139.","journal-title":"Nat Cell Biol"},{"issue":"7313","key":"3782_CR166","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285\u201390.","journal-title":"Nature"},{"issue":"1","key":"3782_CR167","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.stem.2009.06.008","volume":"5","author":"MH Chin","year":"2009","unstructured":"Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009;5(1):111\u201323.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"3782_CR168","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCRESAHA.117.311769","volume":"122","author":"M Adamiak","year":"2018","unstructured":"Adamiak M, Cheng G, Bobis-Wozowicz S, Zhao L, Kedracka-Krok S, Samanta A, et al. Induced Pluripotent Stem cell (iPSC)-Derived extracellular vesicles are Safer and more effective for Cardiac Repair Than iPSCs. Circ Res. 2018;122(2):296\u2013309.","journal-title":"Circ Res"},{"key":"3782_CR169","doi-asserted-by":"crossref","unstructured":"Gazdhar A, Grad I, Gugger M, Feki A, Geiser T. Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung. Eur Respiratory Soc; 2012.","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A1961"},{"issue":"6","key":"3782_CR170","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/scrt513","volume":"5","author":"A Gazdhar","year":"2014","unstructured":"Gazdhar A, Grad I, Tam\u00f2 L, Gugger M, Feki A, Geiser T. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther. 2014;5(6):123.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3782_CR171","first-page":"473","volume":"41","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhang Q, Gao Y, Tan M, Zheng R, Zhao L, et al. Induced pluripotent stem cell-conditioned medium suppresses pulmonary fibroblast-to-myofibroblast differentiation via the inhibition of TGF-\u03b21\/Smad pathway. Int J Mol Med. 2018;41(1):473\u201384.","journal-title":"Int J Mol Med"},{"issue":"3","key":"3782_CR172","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s12015-017-9790-9","volume":"14","author":"L Tam\u00f2","year":"2018","unstructured":"Tam\u00f2 L, Simillion C, Hibaoui Y, Feki A, Gugger M, Prasse A, et al. Gene Network Analysis of Interstitial Macrophages after Treatment with Induced Pluripotent stem cells secretome (iPSC-cm) in the bleomycin injured rat lung. Stem cell Reviews Rep. 2018;14(3):412\u201324.","journal-title":"Stem cell Reviews Rep"},{"key":"3782_CR173","doi-asserted-by":"crossref","unstructured":"Tam\u00f2 L, Fytianos K, Caldana F, Simillion C, Feki A, Nita I et al. Interactome Analysis of iPSC Secretome and its Effect on macrophages in Vitro. Int J Mol Sci. 2021;22(2).","DOI":"10.3390\/ijms22020958"},{"key":"3782_CR174","doi-asserted-by":"crossref","unstructured":"Povero D, Pinatel EM, Leszczynska A, Goyal NP, Nishio T, Kim J et al. Human induced pluripotent stem cell\u2013derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight. 2019;4(14).","DOI":"10.1172\/jci.insight.125652"},{"issue":"5","key":"3782_CR175","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3782_CR176","doi-asserted-by":"publisher","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","volume":"134","author":"M Selman","year":"2001","unstructured":"Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134(2):136\u201351.","journal-title":"Ann Intern Med"},{"key":"3782_CR177","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels P, Moor C, Von der Th\u00fcsen J, Wijsenbeek M, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 2019;147:79\u201391.","journal-title":"Respir Med"},{"issue":"1","key":"3782_CR178","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","volume":"19","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19(1):32.","journal-title":"Respir Res"},{"issue":"1","key":"3782_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/rr162","volume":"3","author":"JT Allen","year":"2001","unstructured":"Allen JT, Spiteri MA. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir Res. 2001;3(1):1\u20139.","journal-title":"Respir Res"},{"key":"3782_CR180","doi-asserted-by":"crossref","unstructured":"Keane MP, Arenberg DA, Lynch JP 3rd, Whyte RI, Iannettoni MD, Burdick MD et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. Journal of immunology (Baltimore, Md: 1950). 1997;159(3):1437-43.","DOI":"10.4049\/jimmunol.159.3.1437"},{"issue":"1","key":"3782_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4965","volume":"48","author":"Z Ye","year":"2021","unstructured":"Ye Z, Hu Y. TGF\u2013\u03b21: gentlemanly orchestrator in idiopathic pulmonary fibrosis. Int J Mol Med. 2021;48(1):1\u201314.","journal-title":"Int J Mol Med"},{"key":"3782_CR182","doi-asserted-by":"crossref","unstructured":"Shenderov K, Collins SL, Powell JD, Horton MR. Immune dysregulation as a driver of idiopathic pulmonary fibrosis. J Clin Invest. 2021;131(2).","DOI":"10.1172\/JCI143226"},{"key":"3782_CR183","doi-asserted-by":"crossref","unstructured":"van Geffen C, Dei\u00dfler A, Quante M, Renz H, Hartl D, Kolahian S. Regulatory Immune cells in idiopathic pulmonary fibrosis: friends or foes? Front Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.663203"},{"issue":"1","key":"3782_CR184","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.immuni.2018.04.023","volume":"49","author":"Y Morimoto","year":"2018","unstructured":"Morimoto Y, Hirahara K, Kiuchi M, Wada T, Ichikawa T, Kanno T, et al. Amphiregulin-producing pathogenic memory T helper 2 cells Instruct eosinophils to secrete osteopontin and facilitate Airway Fibrosis. Immunity. 2018;49(1):134\u2013e506.","journal-title":"Immunity"},{"key":"3782_CR185","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rmed.2018.12.015","volume":"147","author":"P Heukels","year":"2019","unstructured":"Heukels P, Moor CC, von der Thusen JH, Wijsenbeek MS, Kool M. Inflammation and immunity in IPF pathogenesis and treatment. Respir Med. 2019;147:79\u201391.","journal-title":"Respir Med"},{"key":"3782_CR186","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.matbio.2018.03.021","volume":"71","author":"JC Hewlett","year":"2018","unstructured":"Hewlett JC, Kropski JA, Blackwell TS. Idiopathic pulmonary fibrosis: epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biol. 2018;71:112\u201327.","journal-title":"Matrix Biol"},{"key":"3782_CR187","doi-asserted-by":"crossref","unstructured":"Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O et al. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respiratory Review: Official J Eur Respiratory Soc. 2019;28(153).","DOI":"10.1183\/16000617.0044-2019"},{"key":"3782_CR188","doi-asserted-by":"crossref","unstructured":"Richeldi L, Davies HRH, Spagnolo P, Luppi F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Reviews. 2003(3).","DOI":"10.1002\/14651858.CD002880"},{"issue":"1","key":"3782_CR189","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","volume":"5","author":"G Raghu","year":"2017","unstructured":"Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, et al. Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. Lancet Respiratory Med. 2017;5(1):22\u201332.","journal-title":"Lancet Respiratory Med"},{"issue":"2","key":"3782_CR190","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa030511","volume":"350","author":"G Raghu","year":"2004","unstructured":"Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350(2):125\u201333.","journal-title":"N Engl J Med"},{"issue":"21","key":"3782_CR191","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"IPFCR Network","year":"2012","unstructured":"Network IPFCR. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21):1968\u201377.","journal-title":"N Engl J Med"},{"issue":"11","key":"3782_CR192","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.3390\/ijms22116107","volume":"22","author":"N Inui","year":"2021","unstructured":"Inui N, Sakai S, Kitagawa M. Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on pathways related to TGF-\u03b2 and the ubiquitin-proteasome pathway. Int J Mol Sci. 2021;22(11):6107.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3782_CR193","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pulmoe.2018.06.003","volume":"25","author":"E Bargagli","year":"2019","unstructured":"Bargagli E, Piccioli C, Rosi E, Torricelli E, Turi L, Piccioli E, et al. Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: real-life experience in an Italian referral centre. Pulmonology. 2019;25(3):149\u201353.","journal-title":"Pulmonology"},{"issue":"3","key":"3782_CR194","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","volume":"7","author":"PM George","year":"2019","unstructured":"George PM, Patterson CM, Reed AK, Thillai M. Lung transplantation for idiopathic pulmonary fibrosis. Lancet Respiratory Med. 2019;7(3):271\u201382.","journal-title":"Lancet Respiratory Med"},{"issue":"5","key":"3782_CR195","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.surg.2007.10.015","volume":"143","author":"PR Crisostomo","year":"2008","unstructured":"Crisostomo PR, Markel TA, Wang Y, Meldrum DR. Surgically relevant aspects of stem cell paracrine effects. Surgery. 2008;143(5):577\u201381.","journal-title":"Surgery"},{"key":"3782_CR196","doi-asserted-by":"crossref","unstructured":"Schmelzer E, Miceli V, Chinnici CM, Bertani A, Gerlach JC. Effects of mesenchymal stem cell coculture on human lung small airway epithelial cells. BioMed research international. 2020;2020.","DOI":"10.1155\/2020\/9847579"},{"issue":"1","key":"3782_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0081-6","volume":"6","author":"Y-W Lan","year":"2015","unstructured":"Lan Y-W, Choo K-B, Chen C-M, Hung T-H, Chen Y-B, Hsieh C-H, et al. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther. 2015;6(1):1\u201317.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR198","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.biocel.2019.01.017","volume":"109","author":"Y Han","year":"2019","unstructured":"Han Y, Ren J, Bai Y, Pei X, Han Y. Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF\/VEGF-R. Int J Biochem Cell Biol. 2019;109:59\u201368.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"3782_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-11-16","volume":"11","author":"S-H Lee","year":"2010","unstructured":"Lee S-H, Jang A-S, Kim Y-E, Cha J-Y, Kim T-H, Jung S, et al. Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury\/fibrosis. Respir Res. 2010;11(1):1\u201314.","journal-title":"Respir Res"},{"issue":"3","key":"3782_CR200","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/mt.2014.217","volume":"23","author":"M Ono","year":"2015","unstructured":"Ono M, Ohkouchi S, Kanehira M, Tode N, Kobayashi M, Ebina M, et al. Mesenchymal stem cells correct inappropriate epithelial\u2013mesenchyme relation in pulmonary fibrosis using stanniocalcin-1. Mol Ther. 2015;23(3):549\u201360.","journal-title":"Mol Ther"},{"key":"3782_CR201","doi-asserted-by":"crossref","unstructured":"Lv H, Liu Q, Sun Y, Yi X, Wei X, Liu W et al. Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization. Annals Translational Med. 2020;8(6).","DOI":"10.21037\/atm.2020.02.105"},{"issue":"5","key":"3782_CR202","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00109-019-01776-y","volume":"97","author":"LL de Castro","year":"2019","unstructured":"de Castro LL, Lopes-Pacheco M, Weiss DJ, Cruz FF, Rocco PRM. Current understanding of the immunosuppressive properties of mesenchymal stromal cells. J Mol Med. 2019;97(5):605\u201318.","journal-title":"J Mol Med"},{"issue":"1","key":"3782_CR203","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis GR, Fernandez-Gonzalez A, Anastas J, Vitali SH, Liu X, Ericsson M, et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through Macrophage Immunomodulation. Am J Respir Crit Care Med. 2018;197(1):104\u201316.","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"3782_CR204","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.7150\/thno.33741","volume":"9","author":"KA Chu","year":"2019","unstructured":"Chu KA, Wang SY, Yeh CC, Fu TW, Fu YY, Ko TL, et al. Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton\u2019s jelly. Theranostics. 2019;9(22):6646\u201364.","journal-title":"Theranostics"},{"key":"3782_CR205","doi-asserted-by":"crossref","unstructured":"Bayati P, Taherian M, Assarehzadegan M-A, Soleimani M, Poormoghim H, Mojtabavi N. Induced Pluripotent stem-cells inhibit experimental bleomycin-induced pulmonary fibrosis through regulation of the insulin-like growth factor signaling. Iran J Allergy Asthma Immunol. 2022:1\u201310.","DOI":"10.18502\/ijaai.v21i3.9800"},{"key":"3782_CR206","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn S, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19) StatPearls Publishing; 2020. Jan,[Google Scholar]."},{"issue":"10229","key":"3782_CR207","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London England). 2020;395(10229):1033\u20134.","journal-title":"Lancet (London England)"},{"issue":"7","key":"3782_CR208","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811\u20138.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3782_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01849-7","volume":"11","author":"M Kavianpour","year":"2020","unstructured":"Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther. 2020;11(1):1\u201319.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3782_CR210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02216-w","volume":"12","author":"RN Riedel","year":"2021","unstructured":"Riedel RN, P\u00e9rez-P\u00e9rez A, S\u00e1nchez-Margalet V, Varone CL, Maym\u00f3 JL. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? Stem Cell Res Ther. 2021;12(1):1\u201319.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3782_CR211","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12015-020-09973-w","volume":"16","author":"A Golchin","year":"2020","unstructured":"Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for COVID-19: present or future. Stem cell Reviews Rep. 2020;16(3):427\u201333.","journal-title":"Stem cell Reviews Rep"},{"key":"3782_CR212","doi-asserted-by":"crossref","unstructured":"Ojo AS, Balogun SA, Williams OT, Ojo OS. Pulmonary fibrosis in COVID-19 survivors: predictive factors and risk reduction strategies. Pulmonary medicine. 2020;2020.","DOI":"10.1155\/2020\/6175964"},{"issue":"6","key":"3782_CR213","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/hep.23196","volume":"50","author":"SS Choi","year":"2009","unstructured":"Choi SS, Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology (Baltimore MD). 2009;50(6):2007\u201313.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"2","key":"3782_CR214","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/liv.12577","volume":"35","author":"C Cicchini","year":"2015","unstructured":"Cicchini C, Amicone L, Alonzi T, Marchetti A, Mancone C, Tripodi M. Molecular mechanisms controlling the phenotype and the EMT\/MET dynamics of hepatocyte. Liver International: Official J Int Association Study Liver. 2015;35(2):302\u201310.","journal-title":"Liver International: Official J Int Association Study Liver"},{"issue":"1","key":"3782_CR215","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wics.1499","volume":"13","author":"J Berumen","year":"2021","unstructured":"Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: pathophysiology and clinical implications. Wiley Interdisciplinary Reviews Syst Biology Med. 2021;13(1):e1499.","journal-title":"Wiley Interdisciplinary Reviews Syst Biology Med"},{"issue":"6","key":"3782_CR216","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66(6):1300\u201312.","journal-title":"J Hepatol"},{"key":"3782_CR217","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhao Y, Zhang L, Zhang F, Li L. The application of mesenchymal stem cells in the treatment of Liver diseases: mechanism, efficacy, and Safety issues. Front Med. 2021;8.","DOI":"10.3389\/fmed.2021.655268"},{"issue":"1 Suppl","key":"3782_CR218","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/j.jhep.2005.11.028","volume":"44","author":"JM Mir\u00f3","year":"2006","unstructured":"Mir\u00f3 JM, Laguno M, Moreno A, Rimola A. Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol. 2006;44(1 Suppl):S140\u20135.","journal-title":"J Hepatol"},{"key":"3782_CR219","doi-asserted-by":"crossref","unstructured":"Zhang S, Yang Y, Fan L, Zhang F, Li L. The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Annals Translational Med. 2020;8(8).","DOI":"10.21037\/atm.2020.03.218"},{"issue":"2","key":"3782_CR220","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jss.2013.02.009","volume":"183","author":"Z Du","year":"2013","unstructured":"Du Z, Wei C, Cheng K, Han B, Yan J, Zhang M, et al. Mesenchymal stem cell\u2013conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. J Surg Res. 2013;183(2):907\u201315.","journal-title":"J Surg Res"},{"issue":"8","key":"3782_CR221","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1038\/emm.2014.49","volume":"46","author":"MD Kim","year":"2014","unstructured":"Kim MD, Kim SS, Cha HY, Jang SH, Chang DY, Kim W, et al. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Exp Mol Med. 2014;46(8):e110.","journal-title":"Exp Mol Med"},{"issue":"2","key":"3782_CR222","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1096\/fj.201801349RR","volume":"33","author":"Y Liu","year":"2019","unstructured":"Liu Y, Ren H, Wang J, Yang F, Li J, Zhou Y, et al. Prostaglandin E(2) secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2019;33(2):2514\u201325.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"issue":"1","key":"3782_CR223","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13287-020-02070-2","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Liu Y, Ding H, Shi X, Ren H. Mesenchymal stem cell-secreted prostaglandin E(2) ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization. Stem Cell Res Ther. 2021;12(1):15.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3782_CR224","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/lt.25049","volume":"24","author":"M Gazdic","year":"2018","unstructured":"Gazdic M, Markovic BS, Arsenijevic A, Jovicic N, Acovic A, Harrell CR, et al. Crosstalk between mesenchymal stem cells and T regulatory cells is crucially important for the attenuation of acute liver injury. Liver Transpl. 2018;24(5):687\u2013702.","journal-title":"Liver Transpl"},{"issue":"8","key":"3782_CR225","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/lt.24784","volume":"23","author":"N Milosavljevic","year":"2017","unstructured":"Milosavljevic N, Gazdic M, Simovic Markovic B, Arsenijevic A, Nurkovic J, Dolicanin Z, et al. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23(8):1040\u201350.","journal-title":"Liver Transpl"},{"issue":"2","key":"3782_CR226","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.26670","volume":"59","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Cai W, Huang Q, Gu Y, Shi Y, Huang J, et al. Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology (Baltimore MD). 2014;59(2):671\u201382.","journal-title":"Hepatology (Baltimore MD)"},{"key":"3782_CR227","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","volume":"14","author":"B Huang","year":"2016","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016;14:45.","journal-title":"J Transl Med"},{"key":"3782_CR228","doi-asserted-by":"crossref","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga H, Wang D et al. (2016). Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. Journal of Translational Medicine.14:45.","DOI":"10.1186\/s12967-016-0792-1"},{"issue":"5","key":"3782_CR229","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3727\/096368916X693833","volume":"26","author":"SW Lee","year":"2017","unstructured":"Lee SW, Chong JU, Min SO, Bak SY, Kim KS. Are adipose-derived stem cells from liver falciform ligaments another possible source of mesenchymal stem cells? Cell Transpl. 2017;26(5):855\u201366.","journal-title":"Cell Transpl"},{"issue":"5","key":"3782_CR230","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim HJ, Han J, Lee J, Lee G, et al. Milk Fat Globule-EGF factor 8, secreted by Mesenchymal Stem Cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174\u201386.","journal-title":"Gastroenterology"},{"issue":"1","key":"3782_CR231","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"3782_CR232","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.5966\/sctm.2015-0323","volume":"5","author":"YO Jang","year":"2016","unstructured":"Jang YO, Cho MY, Yun CO, Baik SK, Park KS, Cha SK, et al. Effect of function-enhanced mesenchymal stem cells infected with decorin-expressing adenovirus on hepatic fibrosis. Stem Cells Translational Med. 2016;5(9):1247\u201356.","journal-title":"Stem Cells Translational Med"},{"issue":"1","key":"3782_CR233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000510154","volume":"209","author":"J Yao","year":"2020","unstructured":"Yao J, Yu Y, Nyberg SL. Induced pluripotent stem cells for the treatment of liver diseases: novel concepts. Cells Tissues Organs. 2020;209(1):1\u201317.","journal-title":"Cells Tissues Organs"},{"issue":"9","key":"3782_CR234","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1172\/JCI43267","volume":"120","author":"S Espejel","year":"2010","unstructured":"Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Investig. 2010;120(9):3120\u20136.","journal-title":"J Clin Investig"},{"issue":"4","key":"3782_CR235","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12015-011-9330-y","volume":"9","author":"S Asgari","year":"2013","unstructured":"Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem cell Reviews Rep. 2013;9(4):493\u2013504.","journal-title":"Stem cell Reviews Rep"},{"key":"3782_CR236","doi-asserted-by":"crossref","unstructured":"Du Y, Li D, Han C, Wu H, Xu L, Zhang M et al. Exosomes from Human-Induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect liver against Hepatic Ischemia\/ Reperfusion Injury via activating sphingosine kinase and sphingosine-1-Phosphate signaling pathway. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2017;43(2):611\u201325.","DOI":"10.1159\/000480533"},{"key":"3782_CR237","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2741\/s33","volume":"1","author":"M Dobaczewski","year":"2009","unstructured":"Dobaczewski M, Frangogiannis NG. Chemokines and cardiac fibrosis. Front Biosci. 2009;1:391\u2013405.","journal-title":"Front Biosci"},{"issue":"1","key":"3782_CR238","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Reviews Cardiol. 2013;10(1):15\u201326.","journal-title":"Nat Reviews Cardiol"},{"issue":"9","key":"3782_CR239","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309(9):896\u2013908.","journal-title":"JAMA"},{"key":"3782_CR240","doi-asserted-by":"crossref","unstructured":"Kusachi S. Fibrogenesis, cellular and molecular basis. Myocardial infarction and cardiac fibrogenesis New York. Kluwer Acad. 2003:77\u201396.","DOI":"10.1007\/0-387-26476-0_7"},{"issue":"3","key":"3782_CR241","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jcp.22322","volume":"225","author":"G Krenning","year":"2010","unstructured":"Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225(3):631\u20137.","journal-title":"J Cell Physiol"},{"issue":"9","key":"3782_CR242","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3727\/096368911X627552","volume":"21","author":"DK Singla","year":"2012","unstructured":"Singla DK, Ahmed A, Singla R, Yan B. Embryonic stem cells improve cardiac function in doxorubicin-induced cardiomyopathy mediated through multiple mechanisms. Cell Transplant. 2012;21(9):1919\u201330.","journal-title":"Cell Transplant"},{"issue":"6","key":"3782_CR243","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","volume":"48","author":"P M\u00fcller","year":"2018","unstructured":"M\u00fcller P, Lemcke H, David R. Stem cell therapy in heart diseases\u2013cell types, mechanisms and improvement strategies. Cell Physiol Biochem. 2018;48(6):2607\u201355.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"3782_CR244","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1021\/mp2004675","volume":"8","author":"S Neel","year":"2011","unstructured":"Neel S, Singla DK. Induced pluripotent stem (iPS) cells inhibit apoptosis and fibrosis in streptozotocin-induced diabetic rats. Mol Pharm. 2011;8(6):2350\u20137.","journal-title":"Mol Pharm"},{"issue":"1","key":"3782_CR245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11091-2","volume":"10","author":"S-J Park","year":"2019","unstructured":"Park S-J, Kim RY, Park B-W, Lee S, Choi SW, Park J-H, et al. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction. Nat Commun. 2019;10(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"9","key":"3782_CR246","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/hc3501.093817","volume":"104","author":"H Kamihata","year":"2001","unstructured":"Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104(9):1046\u201352.","journal-title":"Circulation"},{"issue":"4","key":"3782_CR247","doi-asserted-by":"publisher","first-page":"e60161","DOI":"10.1371\/journal.pone.0060161","volume":"8","author":"R Kishore","year":"2013","unstructured":"Kishore R, Verma SK, Mackie AR, Vaughan EE, Abramova TV, Aiko I, et al. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PLoS ONE. 2013;8(4):e60161.","journal-title":"PLoS ONE"},{"issue":"1","key":"3782_CR248","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01633-7","volume":"11","author":"L Jin","year":"2020","unstructured":"Jin L, Zhang J, Deng Z, Liu J, Han W, Chen G, et al. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2. Stem Cell Res Ther. 2020;11(1):1\u201313.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"3782_CR249","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/01.RES.0000225952.61196.39","volume":"98","author":"R Uemura","year":"2006","unstructured":"Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circul Res. 2006;98(11):1414\u201321.","journal-title":"Circul Res"},{"key":"3782_CR250","doi-asserted-by":"publisher","first-page":"9108681","DOI":"10.1155\/2018\/9108681","volume":"2018","author":"DN Silva","year":"2018","unstructured":"Silva DN, Souza BSF, Azevedo CM, Vasconcelos JF, de Jesus PG, Feitoza MS, et al. IGF-1-Overexpressing mesenchymal Stem\/Stromal cells promote Immunomodulatory and Proregenerative effects in Chronic Experimental Chagas Disease. Stem Cells Int. 2018;2018:9108681.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3782_CR251","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13287-017-0722-z","volume":"8","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhao Y, Chen W, Xie L, Zhao ZA, Yang J, et al. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Stem Cell Res Ther. 2017;8(1):268.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR252","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","volume":"65","author":"S Djudjaj","year":"2019","unstructured":"Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med. 2019;65:16\u201336.","journal-title":"Mol Aspects Med"},{"issue":"12","key":"3782_CR253","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol. 2011;7(12):684\u201396.","journal-title":"Nat Rev Nephrol"},{"key":"3782_CR254","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","volume":"80","author":"BD Humphreys","year":"2018","unstructured":"Humphreys BD. Mechanisms of Renal Fibrosis. Annu Rev Physiol. 2018;80:309\u201326.","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"3782_CR255","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2016.54","volume":"12","author":"M Edeling","year":"2016","unstructured":"Edeling M, Ragi G, Huang S, Pavenst\u00e4dt H, Susztak K. Developmental signalling pathways in renal fibrosis: the roles of Notch, wnt and hedgehog. Nat Rev Nephrol. 2016;12(7):426\u201339.","journal-title":"Nat Rev Nephrol"},{"key":"3782_CR256","doi-asserted-by":"crossref","unstructured":"Vernon MA, Mylonas KJ, Hughes J, editors. Macrophages and renal fibrosis. Seminars in nephrology. Elsevier; 2010.","DOI":"10.1016\/j.semnephrol.2010.03.004"},{"issue":"3","key":"3782_CR257","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semnephrol.2010.03.006","volume":"30","author":"V Vielhauer","year":"2010","unstructured":"Vielhauer V, Kulkarni O, Reichel CA, Anders HJ. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol. 2010;30(3):318\u201333.","journal-title":"Semin Nephrol"},{"issue":"2","key":"3782_CR258","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00467-011-1772-6","volume":"27","author":"I Grgic","year":"2012","unstructured":"Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012;27(2):183\u201393.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"3782_CR259","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI72271","volume":"124","author":"K Reidy","year":"2014","unstructured":"Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Investig. 2014;124(6):2333\u201340.","journal-title":"J Clin Investig"},{"issue":"2","key":"3782_CR260","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2353\/ajpath.2008.070057","volume":"172","author":"Y Li","year":"2008","unstructured":"Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol. 2008;172(2):299\u2013308.","journal-title":"Am J Pathol"},{"issue":"4","key":"3782_CR261","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2009.05.009","volume":"54","author":"Y Yamaguchi","year":"2009","unstructured":"Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2009;54(4):653\u201364.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"key":"3782_CR262","doi-asserted-by":"crossref","unstructured":"Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, et al. Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment. Volume 101. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine &; 2018. pp. 670\u201381. pharmacotherapie.","DOI":"10.1016\/j.biopha.2018.02.090"},{"issue":"1","key":"3782_CR263","doi-asserted-by":"publisher","first-page":"e115947","DOI":"10.1371\/journal.pone.0115947","volume":"10","author":"D Kumar","year":"2015","unstructured":"Kumar D, Singla SK, Puri V, Puri S. The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. PLoS ONE. 2015;10(1):e115947.","journal-title":"PLoS ONE"},{"key":"3782_CR264","doi-asserted-by":"crossref","unstructured":"Wang W, Wang X, Zhang XS, Liang CZ. Cryptotanshinone Attenuates Oxidative Stress and Inflammation through the Regulation of Nrf-2 and NF-\u03baB in Mice with Unilateral Ureteral Obstruction. Basic & clinical pharmacology & toxicology. 2018;123(6):714\u2009\u2013\u200920.","DOI":"10.1111\/bcpt.13091"},{"key":"3782_CR265","doi-asserted-by":"crossref","unstructured":"Liao Y, Tan RZ, Li JC, Liu TT, Zhong X, Yan Y et al. Isoliquiritigenin attenuates UUO-Induced renal inflammation and fibrosis by inhibiting Mincle\/Syk\/NF-Kappa B Signaling Pathway. Drug design, development and therapy. 2020;14:1455\u201368.","DOI":"10.2147\/DDDT.S243420"},{"issue":"7","key":"3782_CR266","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/jcmm.13060","volume":"21","author":"M Liu","year":"2017","unstructured":"Liu M, Ning X, Li R, Yang Z, Yang X, Sun S, et al. Signalling pathways involved in hypoxia-induced renal fibrosis. J Cell Mol Med. 2017;21(7):1248\u201359.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3782_CR267","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1089\/rej.2018.2104","volume":"22","author":"F Dou","year":"2019","unstructured":"Dou F, Liu Y, Liu L, Wang J, Sun T, Mu F, et al. Aloe-Emodin ameliorates Renal Fibrosis Via inhibiting PI3K\/Akt\/mTOR signaling pathway in vivo and in Vitro. Rejuvenation Res. 2019;22(3):218\u201329.","journal-title":"Rejuvenation Res"},{"key":"3782_CR268","doi-asserted-by":"publisher","first-page":"118465","DOI":"10.1016\/j.lfs.2020.118465","volume":"261","author":"B Deng","year":"2020","unstructured":"Deng B, Yang W, Wang D, Cheng L, Bu L, Rao J, et al. Peptide DR8 suppresses epithelial-to-mesenchymal transition via the TGF-\u03b2\/MAPK signaling pathway in renal fibrosis. Life Sci. 2020;261:118465.","journal-title":"Life Sci"},{"issue":"9","key":"3782_CR269","first-page":"4296","volume":"11","author":"Q Yan","year":"2018","unstructured":"Yan Q, Wang X, Zha M, Yu M, Sheng M, Yu J. The RhoA\/ROCK signaling pathway affects the development of diabetic nephropathy resulting from the epithelial to mesenchymal transition. Int J Clin Exp Pathol. 2018;11(9):4296.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"3782_CR270","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jcm9051328","volume":"9","author":"TM Seccia","year":"2020","unstructured":"Seccia TM, Rigato M, Ravarotto V, Cal\u00f2 LA. ROCK (RhoA\/Rho kinase) in Cardiovascular\u2013Renal Pathophysiology: a review of New Advancements. J Clin Med. 2020;9(5):1328.","journal-title":"J Clin Med"},{"issue":"1","key":"3782_CR271","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jss.2010.06.022","volume":"168","author":"H Asanuma","year":"2011","unstructured":"Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 2011;168(1):e51\u20139.","journal-title":"J Surg Res"},{"issue":"2","key":"3782_CR272","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41390-019-0736-6","volume":"88","author":"D Hu","year":"2020","unstructured":"Hu D, Zhang D, Liu B, Liu Y, Zhou Y, Yu Y, et al. Human ucMSCs seeded in a decellularized kidney scaffold attenuate renal fibrosis by reducing epithelial-mesenchymal transition via the TGF-\u03b2\/Smad signaling pathway. Pediatr Res. 2020;88(2):192\u2013201.","journal-title":"Pediatr Res"},{"issue":"5","key":"3782_CR273","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/sctm.17-0186","volume":"7","author":"X Zou","year":"2018","unstructured":"Zou X, Jiang K, Puranik AS, Jordan KL, Tang H, Zhu X, et al. Targeting murine mesenchymal stem cells to kidney Injury Molecule-1 improves their therapeutic efficacy in chronic ischemic kidney Injury. Stem Cells Translational Med. 2018;7(5):394\u2013403.","journal-title":"Stem Cells Translational Med"},{"issue":"3","key":"3782_CR274","doi-asserted-by":"publisher","first-page":"e92129","DOI":"10.1371\/journal.pone.0092129","volume":"9","author":"G Zhang","year":"2014","unstructured":"Zhang G, Zou X, Miao S, Chen J, Du T, Zhong L, et al. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2\/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS ONE. 2014;9(3):e92129.","journal-title":"PLoS ONE"},{"issue":"3","key":"3782_CR275","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/scrt215","volume":"4","author":"T Du","year":"2013","unstructured":"Du T, Zou X, Cheng J, Wu S, Zhong L, Ju G, et al. Human Wharton\u2019s jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells. Stem Cell Res Ther. 2013;4(3):59.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"3782_CR276","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/14653249.2012.711471","volume":"14","author":"T Du","year":"2012","unstructured":"Du T, Cheng J, Zhong L, Zhao XF, Zhu J, Zhu YJ, et al. The alleviation of acute and chronic kidney injury by human Wharton\u2019s jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy. 2012;14(10):1215\u201327.","journal-title":"Cytotherapy"},{"issue":"5","key":"3782_CR277","doi-asserted-by":"publisher","first-page":"e65042","DOI":"10.1371\/journal.pone.0065042","volume":"8","author":"D Sun","year":"2013","unstructured":"Sun D, Bu L, Liu C, Yin Z, Zhou X, Li X, et al. Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction. PLoS ONE. 2013;8(5):e65042.","journal-title":"PLoS ONE"},{"issue":"10","key":"3782_CR278","first-page":"4289","volume":"8","author":"X Zou","year":"2016","unstructured":"Zou X, Gu D, Xing X, Cheng Z, Gong D, Zhang G, et al. Human mesenchymal stromal cell-derived extracellular vesicles alleviate renal ischemic reperfusion injury and enhance angiogenesis in rats. Am J Translational Res. 2016;8(10):4289\u201399.","journal-title":"Am J Translational Res"},{"issue":"7","key":"3782_CR279","doi-asserted-by":"publisher","first-page":"809","DOI":"10.5966\/sctm.2013-0186","volume":"3","author":"E Baulier","year":"2014","unstructured":"Baulier E, Favreau F, Le Corf A, Jayle C, Schneider F, Goujon JM, et al. Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Translational Med. 2014;3(7):809\u201320.","journal-title":"Stem Cells Translational Med"},{"issue":"2","key":"3782_CR280","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3727\/096368912X655019","volume":"22","author":"T Katsuno","year":"2013","unstructured":"Katsuno T, Ozaki T, Saka Y, Furuhashi K, Kim H, Yasuda K, et al. Low serum cultured adipose tissue-derived stromal cells ameliorate acute kidney injury in rats. Cell Transplant. 2013;22(2):287\u201397.","journal-title":"Cell Transplant"},{"issue":"2","key":"3782_CR281","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt198","volume":"4","author":"JM Quimby","year":"2013","unstructured":"Quimby JM, Webb TL, Habenicht LM, Dow SW. Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies. Stem Cell Res Ther. 2013;4(2):1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"41","key":"3782_CR282","doi-asserted-by":"publisher","first-page":"70707","DOI":"10.18632\/oncotarget.19979","volume":"8","author":"F Zhu","year":"2017","unstructured":"Zhu F, Chong Lee Shin OLS, Pei G, Hu Z, Yang J, Zhu H, et al. Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget. 2017;8(41):70707\u201326.","journal-title":"Oncotarget"},{"issue":"10","key":"3782_CR283","doi-asserted-by":"publisher","first-page":"e0140121","DOI":"10.1371\/journal.pone.0140121","volume":"10","author":"Y Hattori","year":"2015","unstructured":"Hattori Y, Kim H, Tsuboi N, Yamamoto A, Akiyama S, Shi Y, et al. Therapeutic potential of stem cells from human exfoliated deciduous teeth in models of Acute kidney Injury. PLoS ONE. 2015;10(10):e0140121.","journal-title":"PLoS ONE"},{"issue":"1","key":"3782_CR284","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.kint.2016.12.023","volume":"92","author":"A Eirin","year":"2017","unstructured":"Eirin A, Zhu XY, Puranik AS, Tang H, McGurren KA, van Wijnen AJ, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. Kidney Int. 2017;92(1):114\u201324.","journal-title":"Kidney Int"},{"key":"3782_CR285","doi-asserted-by":"publisher","first-page":"173343","DOI":"10.1016\/j.ejphar.2020.173343","volume":"883","author":"Y Yu","year":"2020","unstructured":"Yu Y, Hu D, Zhou Y, Xiang H, Liu B, Shen L, et al. Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-\u03b2\/Smad signaling pathways in vivo and in vitro. Eur J Pharmacol. 2020;883:173343.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3782_CR286","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/nep.13047","volume":"23","author":"IH Song","year":"2018","unstructured":"Song IH, Jung KJ, Lee TJ, Kim JY, Sung EG, Bae YC, et al. Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB. Nephrol (Carlton Vic). 2018;23(5):483\u201392.","journal-title":"Nephrol (Carlton Vic)"},{"issue":"1","key":"3782_CR287","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13287-020-01767-8","volume":"11","author":"Z Shi","year":"2020","unstructured":"Shi Z, Wang Q, Zhang Y, Jiang D. Extracellular vesicles produced by bone marrow mesenchymal stem cells attenuate renal fibrosis, in part by inhibiting the RhoA\/ROCK pathway, in a UUO rat model. Stem Cell Res Ther. 2020;11(1):253.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3782_CR288","doi-asserted-by":"publisher","first-page":"F25","DOI":"10.1152\/ajprenal.00311.2016","volume":"312","author":"F Matsui","year":"2017","unstructured":"Matsui F, Babitz SK, Rhee A, Hile KL, Zhang H, Meldrum KK. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production. Am J Physiol Ren Physiol. 2017;312(1):F25\u201332.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"3782_CR289","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4103\/0366-6999.176088","volume":"129","author":"XD Geng","year":"2016","unstructured":"Geng XD, Zheng W, Wu CM, Wang SQ, Hong Q, Cai GY, et al. Embryonic stem cells-loaded gelatin microcryogels slow progression of chronic kidney disease. Chin Med J. 2016;129(4):392\u20138.","journal-title":"Chin Med J"},{"issue":"2","key":"3782_CR290","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1681\/ASN.2013040367","volume":"25","author":"L De Chiara","year":"2014","unstructured":"De Chiara L, Fagoonee S, Ranghino A, Bruno S, Camussi G, Tolosano E, et al. Renal cells from spermatogonial germline stem cells protect against kidney injury. J Am Soc Nephrology: JASN. 2014;25(2):316\u201328.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"1","key":"3782_CR291","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/s13287-020-02060-4","volume":"11","author":"PC Ribeiro","year":"2020","unstructured":"Ribeiro PC, Lojudice FH, Fernandes-Charpiot IMM, Baptista M, de Almeida Ara\u00fajo S, Mendes GEF, et al. Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease. Stem Cell Res Ther. 2020;11(1):530.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR292","doi-asserted-by":"publisher","first-page":"7428316","DOI":"10.1155\/2017\/7428316","volume":"2017","author":"HC Caldas","year":"2017","unstructured":"Caldas HC, Lojudice FH, Dias C, Fernandes-Charpiot IMM, Baptista M, Kawasaki-Oyama RS, et al. Induced Pluripotent stem cells reduce progression of experimental chronic kidney disease but Develop Wilms\u2019 tumors. Stem Cells Int. 2017;2017:7428316.","journal-title":"Stem Cells Int"},{"issue":"12","key":"3782_CR293","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3727\/096368912X636902","volume":"21","author":"PY Lee","year":"2012","unstructured":"Lee PY, Chien Y, Chiou GY, Lin CH, Chiou CH, Tarng DC. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via downregulating the signaling of oxidative stress and inflammation in ischemia-reperfusion rats. Cell Transpl. 2012;21(12):2569\u201385.","journal-title":"Cell Transpl"},{"issue":"3","key":"3782_CR294","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3727\/096368915X688542","volume":"25","author":"DC Tarng","year":"2016","unstructured":"Tarng DC, Tseng WC, Lee PY, Chiou SH, Hsieh SL. Induced Pluripotent Stem Cell-Derived Conditioned Medium attenuates acute kidney Injury by downregulating the oxidative stress-related pathway in ischemia-reperfusion rats. Cell Transpl. 2016;25(3):517\u201330.","journal-title":"Cell Transpl"},{"issue":"2","key":"3782_CR295","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/cells9020453","volume":"9","author":"F Collino","year":"2020","unstructured":"Collino F, Lopes JA, Tapparo M, Tortelote GG, Kasai-Brunswick TH, Lopes G, et al. Extracellular vesicles derived from induced pluripotent stem cells promote renoprotection in acute kidney injury model. Cells. 2020;9(2):453.","journal-title":"Cells"},{"issue":"2","key":"3782_CR296","first-page":"204","volume":"17","author":"X Huang","year":"2020","unstructured":"Huang X, Wang H, Xu Y. Induced pluripotent stem cells (iPSC)-derived mesenchymal stem cells (MSCs) showed comparable effects in repair of acute kidney injury as compared to adult MSCs. Urol J. 2020;17(2):204\u20139.","journal-title":"Urol J"},{"issue":"3","key":"3782_CR297","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jdermsci.2013.03.005","volume":"70","author":"J Canady","year":"2013","unstructured":"Canady J, Karrer S, Fleck M, Bosserhoff AK. Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions. J Dermatol Sci. 2013;70(3):151\u20138.","journal-title":"J Dermatol Sci"},{"issue":"5","key":"3782_CR298","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1365-2133.2012.11190.x","volume":"167","author":"R Bagabir","year":"2012","unstructured":"Bagabir R, Byers RJ, Chaudhry IH, M\u00fcller W, Paus R, Bayat A. Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. Br J Dermatol. 2012;167(5):1053\u201366.","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"3782_CR299","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.4103\/0970-0358.70730","volume":"43","author":"F Procter","year":"2010","unstructured":"Procter F. Rehabilitation of the burn patient. Indian J Plast Surgery: Official Publication Association Plast Surg India. 2010;43(Suppl):S101\u201313.","journal-title":"Indian J Plast Surgery: Official Publication Association Plast Surg India"},{"issue":"12","key":"3782_CR300","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ptj\/69.12.1014","volume":"69","author":"MA Hardy","year":"1989","unstructured":"Hardy MA. The biology of scar formation. Phys Ther. 1989;69(12):1014\u201324.","journal-title":"Phys Ther"},{"issue":"12","key":"3782_CR301","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00018-012-1152-9","volume":"70","author":"KA Bielefeld","year":"2013","unstructured":"Bielefeld KA, Amini-Nik S, Alman BA. Cutaneous wound healing: recruiting developmental pathways for regeneration. Cell Mol Life Sci. 2013;70(12):2059\u201381.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3782_CR302","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.det.2013.11.002","volume":"32","author":"S Ud-Din","year":"2014","unstructured":"Ud-Din S, Bayat A. New insights on keloids, hypertrophic scars, and striae. Dermatol Clin. 2014;32(2):193\u2013209.","journal-title":"Dermatol Clin"},{"issue":"1","key":"3782_CR303","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/exd.14121","volume":"30","author":"GC Limandjaja","year":"2021","unstructured":"Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. Hypertrophic scars and keloids: overview of the evidence and practical guide for differentiating between these abnormal scars. Exp Dermatol. 2021;30(1):146\u201361.","journal-title":"Exp Dermatol"},{"key":"3782_CR304","doi-asserted-by":"crossref","unstructured":"Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatologic surgery: official publication for American Society for Dermatologic Surgery. 2017;43 Suppl 1:S3-s18.","DOI":"10.1097\/DSS.0000000000000819"},{"issue":"10","key":"3782_CR305","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00403-006-0651-7","volume":"297","author":"O Bock","year":"2006","unstructured":"Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297(10):433\u20138.","journal-title":"Arch Dermatol Res"},{"key":"3782_CR306","doi-asserted-by":"crossref","unstructured":"Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3).","DOI":"10.3390\/ijms18030606"},{"issue":"3","key":"3782_CR307","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1742-481X.2011.00771.x","volume":"8","author":"RL Chalmers","year":"2011","unstructured":"Chalmers RL. The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J. 2011;8(3):218\u201323.","journal-title":"Int Wound J"},{"issue":"3","key":"3782_CR308","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3109\/13880209.2014.918157","volume":"53","author":"T Unahabhokha","year":"2015","unstructured":"Unahabhokha T, Sucontphunt A, Nimmannit U, Chanvorachote P, Yongsanguanchai N, Pongrakhananon V. Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds. Pharm Biol. 2015;53(3):457\u201363.","journal-title":"Pharm Biol"},{"issue":"1\u20133","key":"3782_CR309","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000075030","volume":"176","author":"AD Le","year":"2004","unstructured":"Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, et al. Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs. 2004;176(1\u20133):87\u201394.","journal-title":"Cells Tissues Organs"},{"key":"3782_CR310","doi-asserted-by":"crossref","unstructured":"Gilliam AC. Scleroderma. Current directions in autoimmunity. 2008;10:258\u2009\u2013\u200979.","DOI":"10.1159\/000131502"},{"issue":"2","key":"3782_CR311","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cyto.2011.04.001","volume":"55","author":"K Kurzinski","year":"2011","unstructured":"Kurzinski K, Torok KS. Cytokine profiles in localized scleroderma and relationship to clinical features. Cytokine. 2011;55(2):157\u201364.","journal-title":"Cytokine"},{"issue":"4","key":"3782_CR312","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, Takehara K, Fujimoto M. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatology. 2003;120(4):542\u20137.","journal-title":"J Invest Dermatology"},{"issue":"2","key":"3782_CR313","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","volume":"138","author":"C Nishijima","year":"2004","unstructured":"Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, et al. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Experimental Immunol. 2004;138(2):357\u201363.","journal-title":"Clin Experimental Immunol"},{"issue":"1","key":"3782_CR314","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","volume":"52","author":"S Tomimura","year":"2008","unstructured":"Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, et al. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. J Dermatol Sci. 2008;52(1):47\u201354.","journal-title":"J Dermatol Sci"},{"issue":"9","key":"3782_CR315","first-page":"846","volume":"60","author":"S Young-Min","year":"2001","unstructured":"Young-Min S, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, et al. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud\u2019s phenomenon, and in normal controls. Ann Rheum Dis. 2001;60(9):846\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3782_CR316","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2012;8(1):42\u201354.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"3782_CR317","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","volume":"51","author":"S O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly S, H\u00fcgle T, Van Laar JM. T cells in systemic sclerosis: a reappraisal. Rheumatology. 2012;51(9):1540\u20139.","journal-title":"Rheumatology"},{"issue":"2","key":"3782_CR318","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.0022-202X.2004.23559.x","volume":"124","author":"J-B Jun","year":"2005","unstructured":"Jun J-B, Kuechle M, Min J, Shim SC, Kim G, Montenegro V, et al. Scleroderma fibroblasts demonstrate enhanced activation of akt (protein kinase B) in situ. J Invest Dermatology. 2005;124(2):298\u2013303.","journal-title":"J Invest Dermatology"},{"issue":"5","key":"3782_CR319","doi-asserted-by":"publisher","first-page":"e0156161","DOI":"10.1371\/journal.pone.0156161","volume":"11","author":"S Domergue","year":"2016","unstructured":"Domergue S, Bony C, Maumus M, Toupet K, Frouin E, Rigau V, et al. Comparison between stromal vascular fraction and adipose mesenchymal stem cells in remodeling hypertrophic scars. PLoS ONE. 2016;11(5):e0156161.","journal-title":"PLoS ONE"},{"issue":"2","key":"3782_CR320","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/wrr.12398","volume":"24","author":"MK Lichtman","year":"2016","unstructured":"Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF\u2010\u03b2) isoforms in wound healing and fibrosis. Wound Repair Regeneration. 2016;24(2):215\u201322.","journal-title":"Wound Repair Regeneration"},{"issue":"10","key":"3782_CR321","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1038\/jid.2014.169","volume":"134","author":"S Liu","year":"2014","unstructured":"Liu S, Jiang L, Li H, Shi H, Luo H, Zhang Y, et al. Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J Invest Dermatology. 2014;134(10):2648\u201357.","journal-title":"J Invest Dermatology"},{"issue":"2","key":"3782_CR322","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/etm.2020.9571","volume":"21","author":"F Xie","year":"2021","unstructured":"Xie F, Teng L, Xu J, Lu J, Zhang C, Yang L, et al. Adipose-derived mesenchymal stem cells inhibit cell proliferation and migration and suppress extracellular matrix synthesis in hypertrophic-scar and keloid fibroblasts. Experimental Therapeutic Med. 2021;21(2):139.","journal-title":"Experimental Therapeutic Med"},{"issue":"5\u20136","key":"3782_CR323","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/ten.tea.2016.0550","volume":"24","author":"J Deng","year":"2018","unstructured":"Deng J, Shi Y, Gao Z, Zhang W, Wu X, Cao W, et al. Inhibition of pathological phenotype of hypertrophic scar fibroblasts Via Coculture with adipose-derived stem cells. Tissue Eng Part A. 2018;24(5\u20136):382\u201393.","journal-title":"Tissue Eng Part A"},{"issue":"2","key":"3782_CR324","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdermsci.2016.03.003","volume":"83","author":"F Fang","year":"2016","unstructured":"Fang F, Huang RL, Zheng Y, Liu M, Huo R. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling. J Dermatol Sci. 2016;83(2):95\u2013105.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"3782_CR325","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.burns.2017.08.017","volume":"44","author":"J Liu","year":"2018","unstructured":"Liu J, Ren J, Su L, Cheng S, Zhou J, Ye X, et al. Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling. Burns: J Int Soc Burn Injuries. 2018;44(2):370\u201385.","journal-title":"Burns: J Int Soc Burn Injuries"},{"key":"3782_CR326","doi-asserted-by":"publisher","first-page":"tkab020","DOI":"10.1093\/burnst\/tkab020","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Li S, He L, Chen M. Adipose-derived stem cells inhibit dermal fibroblast growth and induce apoptosis in keloids through the arachidonic acid-derived cyclooxygenase-2\/prostaglandin E2 cascade by paracrine. Burns Trauma. 2021;9:tkab020.","journal-title":"Burns Trauma"},{"issue":"1","key":"3782_CR327","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13287-018-0786-4","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Ma Y, Gao Z, Yang J. Human adipose-derived stem cells inhibit bioactivity of keloid fibroblasts. Stem Cell Res Ther. 2018;9(1):40.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3782_CR328","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5966\/sctm.2013-0120","volume":"3","author":"AI Arno","year":"2014","unstructured":"Arno AI, Amini-Nik S, Blit PH, Al-Shehab M, Belo C, Herer E, et al. Effect of human Wharton\u2019s jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts. Stem Cells Translational Med. 2014;3(3):299\u2013307.","journal-title":"Stem Cells Translational Med"},{"issue":"3","key":"3782_CR329","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/wrr.12046","volume":"21","author":"J Ding","year":"2013","unstructured":"Ding J, Ma Z, Shankowsky HA, Medina A, Tredget EE. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells. Wound Repair Regeneration: Official Publication Wound Healing Soc [and] Eur Tissue Repair Soc. 2013;21(3):448\u201355.","journal-title":"Wound Repair Regeneration: Official Publication Wound Healing Soc [and] Eur Tissue Repair Soc"},{"issue":"5","key":"3782_CR330","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10(5):544\u201355.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3782_CR331","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/emmm.201303000","volume":"6","author":"C Chen","year":"2014","unstructured":"Chen C, Akiyama K, Yamaza T, You YO, Xu X, Li B, et al. Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression. EMBO Mol Med. 2014;6(3):322\u201334.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"3782_CR332","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1756-185X.13764","volume":"23","author":"A Okamura","year":"2020","unstructured":"Okamura A, Matsushita T, Komuro A, Kobayashi T, Maeda S, Hamaguchi Y, et al. Adipose-derived stromal\/stem cells successfully attenuate the fibrosis of scleroderma mouse models. Int J Rheum Dis. 2020;23(2):216\u201325.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"3782_CR333","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/cr.2017.11","volume":"27","author":"C Chen","year":"2017","unstructured":"Chen C, Wang D, Moshaverinia A, Liu D, Kou X, Yu W, et al. Mesenchymal stem cell transplantation in tight-skin mice identifies mir-151-5p as a therapeutic target for systemic sclerosis. Cell Res. 2017;27(4):559\u201377.","journal-title":"Cell Res"},{"issue":"8","key":"3782_CR334","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1002\/jcp.26418","volume":"233","author":"GA Rubio","year":"2018","unstructured":"Rubio GA, Elliot SJ, Wikramanayake TC, Xia X, Pereira-Simon S, Thaller SR, et al. Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing. J Cell Physiol. 2018;233(8):5503\u201312.","journal-title":"J Cell Physiol"},{"issue":"4","key":"3782_CR335","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.3892\/mmr.2014.3115","volume":"11","author":"Y Ren","year":"2015","unstructured":"Ren Y, Deng CL, Wan WD, Zheng JH, Mao GY, Yang SL. Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation. Mol Med Rep. 2015;11(4):2471\u20136.","journal-title":"Mol Med Rep"},{"issue":"3","key":"3782_CR336","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.scr.2012.12.004","volume":"10","author":"M Azhdari","year":"2013","unstructured":"Azhdari M, Baghaban-Eslaminejad M, Baharvand H, Aghdami N. Therapeutic potential of human-induced pluripotent stem cell-derived endothelial cells in a bleomycin-induced scleroderma mouse model. Stem cell Res. 2013;10(3):288\u2013300.","journal-title":"Stem cell Res"},{"issue":"5","key":"3782_CR337","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/stmcls\/sxad014","volume":"41","author":"DF Doherty","year":"2023","unstructured":"Doherty DF, Roets L, Krasnodembskaya AD. The role of Lung Resident Mesenchymal stromal cells in the Pathogenesis and repair of chronic lung disease. Stem Cells. 2023;41(5):431\u201343.","journal-title":"Stem Cells"},{"issue":"3","key":"3782_CR338","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41374-019-0316-8","volume":"100","author":"H Cao","year":"2020","unstructured":"Cao H, Chen X, Hou J, Wang C, Xiang Z, Shen Y, et al. The Shh\/Gli signaling cascade regulates myofibroblastic activation of lung-resident mesenchymal stem cells via the modulation of Wnt10a expression during pulmonary fibrogenesis. Lab Invest. 2020;100(3):363\u201377.","journal-title":"Lab Invest"},{"issue":"1","key":"3782_CR339","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12964-022-00921-4","volume":"20","author":"W Sun","year":"2022","unstructured":"Sun W, Liu X, Yang X, Jing X, Duan C, Yang G, et al. SENP1 regulates the transformation of lung resident mesenchymal stem cells and is associated with idiopathic pulmonary fibrosis progression. Cell Commun Signal. 2022;20(1):104.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"3782_CR340","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12931-023-02606-z","volume":"24","author":"Y Lu","year":"2023","unstructured":"Lu Y, Liu Z, Zhang Y, Wu X, Bian W, Shan S, et al. METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21\/PTEN pathway. Respir Res. 2023;24(1):300.","journal-title":"Respir Res"},{"issue":"9","key":"3782_CR341","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ajpath.2015.06.004","volume":"185","author":"S Kaur","year":"2015","unstructured":"Kaur S, Siddiqui H, Bhat MH. Hepatic progenitor cells in action: liver regeneration or fibrosis? Am J Pathol. 2015;185(9):2342\u201350.","journal-title":"Am J Pathol"},{"issue":"1","key":"3782_CR342","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13287-016-0330-3","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yu X, Chen E, Li L. Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases. Stem Cell Res Ther. 2016;7(1):71.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR343","doi-asserted-by":"crossref","unstructured":"Overi D, Carpino G, Cardinale V, Franchitto A, Safarikia S, Onori P et al. Contribution of Resident Stem cells to liver and biliary tree regeneration in Human diseases. Int J Mol Sci. 2018;19(10).","DOI":"10.3390\/ijms19102917"},{"issue":"1","key":"3782_CR344","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13287-021-02266-0","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang J, Kong Y, Xie C, Zhou L. Stem\/progenitor cell in kidney: characteristics, homing, coordination, and maintenance. Stem Cell Res Ther. 2021;12(1):197.","journal-title":"Stem Cell Res Ther"},{"key":"3782_CR345","doi-asserted-by":"publisher","first-page":"8387350","DOI":"10.1155\/2019\/8387350","volume":"2019","author":"Q Zhuang","year":"2019","unstructured":"Zhuang Q, Ma R, Yin Y, Lan T, Yu M, Ming Y. Mesenchymal stem cells in Renal Fibrosis: the flame of Cytotherapy. Stem Cells Int. 2019;2019:8387350.","journal-title":"Stem Cells Int"},{"key":"3782_CR346","doi-asserted-by":"publisher","first-page":"2543171","DOI":"10.1155\/2019\/2543171","volume":"2019","author":"Y-H Peng","year":"2019","unstructured":"Peng Y-H, Xiao J, Yan C, Luo L, Li T-S. Potential role of the Resident Mesenchymal Stem-Like cells in renal fibrogenesis after Ureteral obstruction. Stem Cells Int. 2019;2019:2543171.","journal-title":"Stem Cells Int"},{"key":"3782_CR347","doi-asserted-by":"publisher","first-page":"7471582","DOI":"10.1155\/2017\/7471582","volume":"2017","author":"A Mauretti","year":"2017","unstructured":"Mauretti A, Spaans S, Bax NAM, Sahlgren C, Bouten CVC. Cardiac progenitor cells and the interplay with their Microenvironment. Stem Cells Int. 2017;2017:7471582.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3782_CR348","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13578-024-01211-x","volume":"14","author":"R Bryl","year":"2024","unstructured":"Bryl R, Kulus M, Bryja A, Domaga\u0142a D, Mozdziak P, Antosik P, et al. Cardiac progenitor cell therapy: mechanisms of action. Cell Bioscience. 2024;14(1):30.","journal-title":"Cell Bioscience"},{"key":"3782_CR349","doi-asserted-by":"crossref","unstructured":"Bracco Gartner TCL, Deddens JC, Mol EA, Magin Ferrer M, van Laake LW, Bouten CVC et al. Anti-fibrotic effects of Cardiac Progenitor cells in a 3D-Model of human Cardiac Fibrosis. Front Cardiovasc Med. 2019;6.","DOI":"10.3389\/fcvm.2019.00052"},{"key":"3782_CR350","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fcvm.2017.00047","volume":"4","author":"YY Leong","year":"2017","unstructured":"Leong YY, Ng WH, Ellison-Hughes GM, Tan JJ. Cardiac stem cells for myocardial regeneration: they are not alone. Front Cardiovasc Med. 2017;4:47.","journal-title":"Front Cardiovasc Med"},{"key":"3782_CR351","doi-asserted-by":"crossref","unstructured":"Novis T, Takiya CM. Chapter 9 - Skin Resident Stem Cells. In: Coeli dos Santos Goldenberg R, Campos de Carvalho A, editors. Resident Stem Cells and Regenerative Therapy (Second Edition). San Diego: Academic Press; 2024. pp. 205\u2009\u2013\u200949.","DOI":"10.1016\/B978-0-443-15289-4.00005-6"},{"key":"3782_CR352","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Garc\u00eda D, Filipov\u00e1 A, Garza-Veloz I, Martinez-Fierro ML. A Beginner\u2019s Introduction to Skin Stem Cells and Wound Healing. Int J Mol Sci. 2021;22(20).","DOI":"10.3390\/ijms222011030"},{"issue":"11","key":"3782_CR353","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1600-0625.2009.00942.x","volume":"18","author":"K Lau","year":"2009","unstructured":"Lau K, Paus R, Tiede S, Day P, Bayat A. Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol. 2009;18(11):921\u201333.","journal-title":"Exp Dermatol"},{"key":"3782_CR354","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/sci.2019.06.04","volume":"6","author":"N Rajabzadeh","year":"2019","unstructured":"Rajabzadeh N, Fathi E, Farahzadi R. Stem cell-based regenerative medicine. Stem Cell Investig. 2019;6:19.","journal-title":"Stem Cell Investig"},{"key":"3782_CR355","first-page":"8106818","volume":"2019","author":"Z Li","year":"2019","unstructured":"Li Z, Hu X, Zhong JF. Mesenchymal stem cells: characteristics, function, and application. Stem Cells Int. 2019;2019:8106818.","journal-title":"Stem Cells Int"},{"issue":"11","key":"3782_CR356","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/cells12111463","volume":"12","author":"H Kang","year":"2023","unstructured":"Kang H, Yang S, Lee J. Tauroursodeoxycholic acid enhances osteogenic differentiation through EGFR\/p-Akt\/CREB1 pathway in mesenchymal stem cells. Cells. 2023;12(11):1463.","journal-title":"Cells"},{"issue":"8","key":"3782_CR357","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.biotechadv.2019.107447","volume":"37","author":"MN Hsu","year":"2019","unstructured":"Hsu MN, Chang YH, Truong VA, Lai PL, Nguyen TKN, Hu YC. CRISPR technologies for stem cell engineering and regenerative medicine. Biotechnol Adv. 2019;37(8):107447.","journal-title":"Biotechnol Adv"},{"key":"3782_CR358","doi-asserted-by":"publisher","first-page":"591065","DOI":"10.3389\/fimmu.2020.591065","volume":"11","author":"S Dabrowska","year":"2020","unstructured":"Dabrowska S, Andrzejewska A, Janowski M, Lukomska B. Immunomodulatory and Regenerative effects of mesenchymal stem cells and extracellular vesicles: Therapeutic Outlook for Inflammatory and degenerative diseases. Front Immunol. 2020;11:591065.","journal-title":"Front Immunol"},{"key":"3782_CR359","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.omtm.2021.01.003","volume":"20","author":"MJR Ruigrok","year":"2021","unstructured":"Ruigrok MJR, Frijlink HW, Melgert BN, Olinga P, Hinrichs WLJ. Gene therapy strategies for idiopathic pulmonary fibrosis: recent advances, current challenges, and future directions. Mol Ther Methods Clin Dev. 2021;20:483\u201396.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3782_CR360","doi-asserted-by":"publisher","first-page":"602647","DOI":"10.3389\/fcell.2020.602647","volume":"8","author":"A Coelho","year":"2020","unstructured":"Coelho A, Alvites RD, Branquinho MV, Guerreiro SG, Maur\u00edcio AC. Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: Literature Research. Front Cell Dev Biol. 2020;8:602647.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"3782_CR361","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"key":"3782_CR362","doi-asserted-by":"crossref","unstructured":"Kim H, Kumbar SG, Nukavarapu SP. Biomaterial-directed cell behavior for tissue engineering. Curr Opin Biomed Eng. 2021;17.","DOI":"10.1016\/j.cobme.2020.100260"},{"key":"3782_CR363","doi-asserted-by":"crossref","unstructured":"Scafa Udri\u0219te A, Niculescu AG, Iliu\u021b\u0103 L, Bajeu T, Georgescu A, Grumezescu AM et al. Progress Biomaterials Cardiac Tissue Eng Regeneration Polym (Basel). 2023;15(5).","DOI":"10.3390\/polym15051177"},{"issue":"1","key":"3782_CR364","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13287-021-02551-y","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Yan Z, Liu Y, Zhang Y, Shi J, Li J, et al. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application. Stem Cell Res Ther. 2021;12(1):470.","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"3782_CR365","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3390\/ph15121485","volume":"15","author":"CH Park","year":"2022","unstructured":"Park CH, Yoo T-H. TGF-\u03b2 inhibitors for therapeutic management of kidney fibrosis. Pharmaceuticals. 2022;15(12):1485.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"3782_CR366","doi-asserted-by":"publisher","first-page":"2103146","DOI":"10.1183\/13993003.03146-2021","volume":"59","author":"O Burgy","year":"2022","unstructured":"Burgy O, Crestani B, Bonniaud P. Targeting the nasty nestin to shoot lung fibrosis. Eur Respir J. 2022;59(5):2103146.","journal-title":"Eur Respir J"},{"issue":"1","key":"3782_CR367","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.","journal-title":"Mol Cancer"},{"issue":"5","key":"3782_CR368","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40265-021-01487-0","volume":"81","author":"YN Lamb","year":"2021","unstructured":"Lamb YN, Nintedanib. A review in Fibrotic interstitial lung diseases. Drugs. 2021;81(5):575\u201386.","journal-title":"Drugs"},{"issue":"1","key":"3782_CR369","first-page":"e12482","volume":"13","author":"PV Shah","year":"2021","unstructured":"Shah PV, Balani P, Lopez AR, Nobleza CMN, Siddiqui M, Khan S. A review of Pirfenidone as an anti-fibrotic in idiopathic pulmonary fibrosis and its probable role in other diseases. Cureus. 2021;13(1):e12482.","journal-title":"Cureus"},{"issue":"5","key":"3782_CR370","first-page":"908","volume":"50","author":"JJ Wei","year":"2021","unstructured":"Wei JJ, Tang L, Chen LL, Xie ZH, Ren Y, Qi HG, et al. Mesenchymal stem cells attenuates TGF-\u03b21-Induced EMT by increasing HGF expression in HK-2 cells. Iran J Public Health. 2021;50(5):908\u201318.","journal-title":"Iran J Public Health"},{"key":"3782_CR371","doi-asserted-by":"publisher","first-page":"910592","DOI":"10.3389\/fcell.2022.910592","volume":"10","author":"J Wang","year":"2022","unstructured":"Wang J, Lin Y, Chen X, Liu Y, Zhou T. Mesenchymal stem cells: a new therapeutic tool for chronic kidney disease. Front Cell Dev Biol. 2022;10:910592.","journal-title":"Front Cell Dev Biol"},{"key":"3782_CR372","doi-asserted-by":"crossref","unstructured":"Qin L, Liu N, Bao C-l et al. Yang D-z, Ma G-x, Yi W-h,. Mesenchymal stem cells in fibrotic diseases\u2014the two sides of the same coin. Acta Pharmacologica Sinica. 2023;44(2):268\u2009\u2013\u200987.","DOI":"10.1038\/s41401-022-00952-0"},{"issue":"3","key":"3782_CR373","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","volume":"46","author":"SK Madala","year":"2012","unstructured":"Madala SK, Schmidt S, Davidson C, Ikegami M, Wert S, Hardie WD. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am J Respir Cell Mol Biol. 2012;46(3):380\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3782_CR374","doi-asserted-by":"crossref","unstructured":"Turner NA, Blythe NM. Cardiac fibroblast p38 MAPK: a critical Regulator of myocardial remodeling. J Cardiovasc Dev Dis. 2019;6(3).","DOI":"10.3390\/jcdd6030027"},{"key":"3782_CR375","doi-asserted-by":"publisher","first-page":"115500","DOI":"10.1016\/j.taap.2021.115500","volume":"418","author":"H Guo","year":"2021","unstructured":"Guo H, Jian Z, Liu H, Cui H, Deng H, Fang J, et al. TGF-\u03b21-induced EMT activation via both smad-dependent and MAPK signaling pathways in Cu-induced pulmonary fibrosis. Toxicol Appl Pharmcol. 2021;418:115500.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"1","key":"3782_CR376","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","volume":"35","author":"Q Wu","year":"2020","unstructured":"Wu Q, Wu W, Jacevic V, Franca TCC, Wang X, Kuca K. Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. J Enzyme Inhib Med Chem. 2020;35(1):574\u201383.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3782_CR377","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fphar.2019.00625","volume":"10","author":"M Li","year":"2019","unstructured":"Li M, Cui L, Feng X, Wang C, Zhang Y, Wang L, et al. Losmapimod protected epileptic rats from hippocampal neuron damage through inhibition of the MAPK pathway. Front Pharmacol. 2019;10:625.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3782_CR378","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13287-017-0734-8","volume":"8","author":"L Pedrazza","year":"2017","unstructured":"Pedrazza L, Cubillos-Rojas M, de Mesquita FC, Luft C, Cunha AA, Rosa JL, et al. Mesenchymal stem cells decrease lung inflammation during sepsis, acting through inhibition of the MAPK pathway. Stem Cell Res Ther. 2017;8(1):289.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"3782_CR379","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41419-024-06620-x","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xia X, Yao M, Yang Y, Ao X, Zhang Z, et al. The dual role of mesenchymal stem cells in apoptosis regulation. Cell Death Dis. 2024;15(4):250.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3782_CR380","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41419-019-1622-1","volume":"10","author":"J Chen","year":"2019","unstructured":"Chen J, Ji T, Wu D, Jiang S, Zhao J, Lin H, et al. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin \u03b15 in hepatocellular carcinoma. Cell Death Dis. 2019;10(6):425.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3782_CR381","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-018-07858-8","volume":"10","author":"HV Woodcock","year":"2019","unstructured":"Woodcock HV, Eley JD, Guillotin D, Plat\u00e9 M, Nanthakumar CB, Martufi M, et al. The mTORC1\/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2019;10(1):6.","journal-title":"Nat Commun"},{"key":"3782_CR382","doi-asserted-by":"crossref","unstructured":"Lawrence J, Nho R. The role of the mammalian target of Rapamycin (mTOR) in Pulmonary Fibrosis. Int J Mol Sci. 2018;19(3).","DOI":"10.3390\/ijms19030778"},{"key":"3782_CR383","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1183\/16000617.0269-2020","volume":"29","author":"M Plat\u00e9","year":"2020","unstructured":"Plat\u00e9 M, Guillotin D, Chambers RC. The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis. Eur Respir Rev. 2020;29:157.","journal-title":"Eur Respir Rev"},{"issue":"18","key":"3782_CR384","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1111\/bph.15898","volume":"179","author":"E Gonz\u00e1lez-S\u00e1nchez","year":"2022","unstructured":"Gonz\u00e1lez-S\u00e1nchez E, Mu\u00f1oz-Callejas A, G\u00f3mez-Rom\u00e1n J, San Antonio E, Marengo A, Tsapis N, et al. Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice. Br J Pharmacol. 2022;179(18):4534\u201348.","journal-title":"Br J Pharmacol"},{"key":"3782_CR385","doi-asserted-by":"publisher","first-page":"120150","DOI":"10.1016\/j.lfs.2021.120150","volume":"288","author":"T Shigematsu","year":"2022","unstructured":"Shigematsu T, Tajima S, Fu R, Zhang M, Itoyama Y, Tsuchimoto A, et al. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci. 2022;288:120150.","journal-title":"Life Sci"},{"issue":"14","key":"3782_CR386","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.3390\/ijms22147743","volume":"22","author":"L Pandolfi","year":"2021","unstructured":"Pandolfi L, Marengo A, Japiassu KB, Frangipane V, Tsapis N, Bincoletto V, et al. Liposomes loaded with Everolimus and coated with Hyaluronic Acid: a Promising Approach for Lung Fibrosis. Int J Mol Sci. 2021;22(14):7743.","journal-title":"Int J Mol Sci"},{"key":"3782_CR387","doi-asserted-by":"crossref","unstructured":"Gomez-Manjarres DC, Axell-House DB, Patel DC, Odackal J, Yu V, Burdick MD et al. Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial. JCI Insight. 2023;8(8).","DOI":"10.1172\/jci.insight.166901"},{"issue":"6","key":"3782_CR388","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/BOR.0b013e32834b3309","volume":"23","author":"AP Lam","year":"2011","unstructured":"Lam AP, Gottardi CJ. \u03b2-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol. 2011;23(6):562\u20137.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"3782_CR389","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/labinvest.2015.154","volume":"96","author":"C Bergmann","year":"2016","unstructured":"Bergmann C, Distler JHW. Canonical wnt signaling in systemic sclerosis. Lab Invest. 2016;96(2):151\u20135.","journal-title":"Lab Invest"},{"issue":"6","key":"3782_CR390","first-page":"960","volume":"9","author":"K Duspara","year":"2021","unstructured":"Duspara K, Bojanic K, Pejic JI, Kuna L, Kolaric TO, Nincevic V, et al. Targeting the wnt signaling pathway in Liver Fibrosis for Drug options: an update. J Clin Transl Hepatol. 2021;9(6):960\u201371.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"3782_CR391","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s13287-023-03581-4","volume":"14","author":"P Bayati","year":"2023","unstructured":"Bayati P, Taherian M, Soleimani M, Farajifard H, Mojtabavi N. Induced pluripotent stem cells modulate the wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis. Stem Cell Res Ther. 2023;14(1):343.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"3782_CR392","doi-asserted-by":"publisher","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","volume":"304","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg M, Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiology-Cell Physiol. 2013;304(3):C216\u201325.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"3","key":"3782_CR393","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/liv.15157","volume":"42","author":"SR Rahman","year":"2022","unstructured":"Rahman SR, Roper JA, Grove JI, Aithal GP, Pun KT, Bennett AJ. Integrins as a drug target in liver fibrosis. Liver Int. 2022;42(3):507\u201321.","journal-title":"Liver Int"},{"issue":"7835","key":"3782_CR394","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555\u201366.","journal-title":"Nature"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03782-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:10:15Z","timestamp":1718669415000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":394,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03782-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}